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VALIDITY OF NUMERICAL VALUES IN REPORTING 
LABORATORY RESULTS
The value reported from a clinical laboratory after determination of 
the concentration or amount of a substance in a specimen represents the best 
value obtainable with the method, reagents, instruments, and technical per­
sonnel involved in obtaining and processing the material.
Accuracy is the degree of agreement of the determination with the 
"true” value (eg, the known concentration in a control sample). Precision de­
notes the reproducibility of the analysis and is expressed in terms of variation 
among several determinations on the same sample. Reliability is a measure 
of the congruence of accuracy and precision.
Precision is not absolute but is subject to variation inherent in the 
complexity of the method, the stability of reagents, the accuracy of the prima­
ry standard, the sophistication of the equipment, and the skill of the technical 
personnel. Each laboratory should maintain data on precision (reproducibili­
ty) that can be expressed statistically in terms of the standard deviation from 
the mean value obtained by repeated analyses of the same sample. For exam­
ple, the precision in determination of cholesterol in serum in a good laborato­
ry may be the mean value ± 5 mg/dL. The 95% confidence limits are ± 2 SD, 
or ± 10 mg/dL. Thus, any value reported is "accurate" within a range of 20 
mg/dL. Thus, the reported value 200 mg/dL means that the true value lies be­
tween 190 and 210 mg/dL. For the determination of serum potassium with a 
variance of 1 SD of ± 0.1 mmol/L, values ± 0.2 mmol could be obtained on 
the same specimen. A report o f 5.5 could represent at best the range 5.3-5.7 
mmol/L. That is, the 2 results - 5.3 and 5.7 mmol/L - might be obtained on 
analysis of the same sample and still be within the limits of precision of the 
test.
Physicians should obtain from the laboratory the values for the varia­
tion of a given determination as a basis for deciding whether one reported 
value represents a change from another on the same patient.
Interpretation of laboratory tests
Normal values are those that fall within 2 standard deviations from 
the mean value for the normal population. This normal range encompasses 
95% of the population. Many factors may affect values and influence the 
normal range; by the same token, various factors may produce values that are 
normal under the prevailing conditions but outside the 95% limits determined 
under other circumstances. These factors include age; race; sex; environ­
ment; posture; diurnal and other cyclic variations; fasting or postpran­
dial state, foods eaten; drugs; and level of exercise.
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Normal or reference values vary with the method employed, the la­
boratory, and conditions of collection and preservation of specimens. The 
normal values established by individual laboratories should be clearly ex­
pressed to ensure proper interpretation.
Interpretation of laboratory results must always be related to the con­
dition of the patient. A low value may be the result of deficit or of dilution of 
the substance measured, eg, low serum sodium. Deviation from normal may 
be associated with a specific disease or with some drug consumed by the sub­
ject - eg, elevated serum uric acid levels may occur in patients with gout or 
may be due to treatment with chlorothiazides or with antineoplastic agents. 
The reader should consult an appropriate text for lists of drugs interfering 
with chemical tests.
Values may be influenced by the method of collection of the speci­
men. Inaccurate collection of a 24-hour urine specimen, variations in concen­
tration of the randomly collected mine specimen, hemolysis in a blood sam­
ple, addition of an inappropriate anticoagulant, and contaminated glassware 
or other apparatus are examples of causes of erroneous results.
Note: Whenever an unusual or abnormal result is obtained, all possi­
ble sources of error must be considered before responding with therapy based 
on the laboratory report. Laboratory medicine is a specialty, and experts in 
the field should be consulted whenever results are unusual or in doubt.
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THE INSTRUCTION ON SAFE WORK OF STUDENTS 
IN EDUCATIONAL LABORATORIES IN THE CHAIR OF THE 
GENERAL AND CLINICAL BIOCHEMISTRY
1. The student should put on white coat, pick up long hair, if neces­
sary, before the beginning of lesson.
2. Each student should be trained established laboratory work safety 
methods before conduct of laboratory work.
3. All manipulations with reactants during conduct of laboratory work 
are necessary to carry out on a workplace (a laboratory table or hood).
4. Work with the cracked glass laboratory ware is strictly prohibited.
5. It should be treated a tip of a pipette by little piece of cotton wool 
moistened with alcohol before mouth pipetting.
6. Precautions for a work with strong reactants:
6.1. Chemicals (concentrated acids, alkalies, etc.) stored in hoods 
should not take out on a laboratory table.
6.2. Mouth pipetting of strong reactants is strictly prohibited. For this 
purpose it is necessary to apply a syringe with a rubber tube.
6.3. The test tube should be stood in a support during strong reactants 
pipetting.
6.4. Prevent spilling of strong reactants splashes on the skin and in to 
the eyes.
First aid in case of spilling of acid and alkali splashes on the skin:
1) Wash the affected part with plenty of water; 2) apply cotton wool 
soaked in 2% sodium carbonate solution if acid spilling, in 2% acetic acid, if 
alkali spilling over the affected part; 3) consult a physician.
First aid in case spilling of acid and alkali splashes into the eye:
1) Wash the eyes immediately with plenty of tap water. Squirt water 
into the comer of the eye near the nose; 2) consult ophthalmologist imme­
diately.
The indicated solutions and medicine chest are in laboratory room 
(room№ 415).
7. Precautions for a work with a spirit-lamp:
7.1. It is necessary to observe rules of fire-prevention safety.
7.2. Spirit-lamp taking out a on a laboratory table is strictly prohi­
bited.
7.3. Before spirit-lamp ignition it is necessary to check up, whether 
will shift a match from its case (for prevention of spirit steams ignition).
7.4. It is necessary to use the test-tube holder and carefully to move a 
test tube over a flame for its even heating.
Thus the test tube should be directed in a safe place (or wall), but not 
to itself or side by side with working student.
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7.5. It is impossible to leave a burning spirit-lamp without supervi­
sion.
7.6. It is necessary to put on a cap on a wick of spirit-lamp at end of
work.
8. Any questions regarding the safety precautions and labour 
safety should be addressed to teacher or laboratory assistant.
WITH SAFETY PRECAUTIONS REGULATIONS 
IS ACQUAINTED AND INSTRUCTED
Student_________________
The signature of the student
Teacher________________
The signature of the teacher 
Date___________________
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THE MAIN BIOCHEMICAL VALUES IN BLOOD SERUM AND
URINE
Values Diagnostic significance
In serum
К serum 
3.5-5.5 mmol/l
Potassium concentration in plasma determines neuro­
muscular and muscular irritability. Elevated or de­
creased concentrations impair the capability of muscle 
tissue to contract.
1. Elevated in renal insufficiency (especially in the 
presence of increased rate of protein or tissue break 
down); adrenal insufficiency (especially hypoaldoste- 
ronism, Addison’s disease); hyporeninemic hypoaldos- 
teronism; dehydration; use of spironolactone; too rapid 
administration of potassium salts, especially intrave­
nously; and use of triamterene or phenformin.
2. Decreased in inadequate intake (starvation); inade­
quate absorption or unusual enteric losses -  Vomiting, 
diarrhea, malabsorption syndrome, or use of sodium 
polystyrene sulfonate resin; unusual renal loss -  sec­
ondary to hyperadrenocorticism (especially hyperal­
dosteronism, Conn’s syndrome) and to adrenocorticos- 
teroid therapy, metabolic alkalosis, use of diuretics 
such as chlorothiazide and its derivatives and the mer­
curials; renal tubular defects such as the de Toni- 
Fanconi syndrome and renal tubular acidosis; treat­
ment with antibiotics that are excreted as anions (car- 
benicillin, ticarcillin); use of phenothiazines, amphote­
ricin B, and drugs with high sodium content; and use 
of degraded tetracycline; abnormal redistribution be­
tween extracellular and intracellular fluids -  Familial 
periodic paralysis or testosterone administration.
Na serum 
130-150 mmol/l
Most of the exchangeable sodium is in the extracellu­
lar fluid. With its associated anions sodium provides 
the bulk of osmotically active solute in the plasma, 
thus affecting the distribution of body water signifi­
cantly. A shift of sodium into cells or a loss of sodium 
from the body results in a decrease of extracellular 
fluid volume, affecting circulation, renal function, and 
nervous system function.
1. Elevated in dehydration (water deficit), central 
nervous system trauma or disease, and 
hyperadrenocorticism with hyperaldosteronism or
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corticosterone of corticosteroid excess.
2. Decreased in adrenal insufficiency; in renal in 
sufficiency, especially with inadequate sodium intake; 
in renal tubular acidosis; as a physiologic response to 
trauma or bums (sodium shift into cells); in unusual 
losses via the gastrointestinal tract, as with acute or 
chronic diarrhea or with intestinal obstruction or 
fistula; and in unusual sweating with inadequate 
sodium replacement.
Ca serum 
2-3 mmol/l
Endocrine, renal, gastrointestinal, and nutritional fac­
tors normally provide for precise regulation of calcium 
concentration in plasma and other body fluids. Since 
some calcium is bound to plasma protein, especially 
albumin, determination of the plasma albumin concen­
tration is necessary before the clinical significance of 
abnormal serum calcium levels can be interpreted ac­
curately.
1. Elevated in hyperparathyroidism, secretion of para­
thyroidlike hormone by malignant tumors, vitamin D 
excess, milk-alkali syndrome, osteolytic disease such 
as multiple myeloma, invasion of bone by metastatic 
cancer, Paget's disease of bone, Boeck's sarcoid, im­
mobilization, and familial hypocalciuria. Occasionally 
elevated with hyperthyroidism and with ingestion of 
thiazide drugs.
2. Decreased in hypoparathryoidism, vitamin D defi­
ciency (rickets, osteomalacia), renal insufficiency, hy- 
poproteinemia, malabsorption syndrome (sprue, ileitis, 
celiac disease, pancreatic insufficiency), severe 
pancreatitis with pancreatic necrosis, and pseudohypo­
parathyroidism.
Alanin
Aminotransferase
(ALT)
<40 U/L,
0.1-0.68 mmol/ (h*l)
ALT is a cytoplasmic enzyme found in high concentra­
tions in liver, heart muscle. Elevations of concentra­
tions of this enzyme in the blood indicate liver disease. 
Elevated after acute infectious hepatitis of viral or tox­
ic origin (ALT usually elevated more than AST); cirr­
hosis of the liver (AST usually elevated more than 
ALT); metastatic or primary liver neoplasm and jaun­
dice.
Aspartate
Aminotransferase
(AST)
<40 U/L,
AST is found in heart muscle, liver, some also in ske­
letal muscle, kidneys and the pancreas. AST is found 
in both cytoplasm and mitochondria. It may be noted 
that AST is more specific for the diagnosis of heart
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0.1-0.45 mmol/ (h*l) diseases.
1. Elevated after myocardial infarction This enzyme 
shows an elevation 8-12 hours after infarction. Peak 
levels are reached 24-48 hours after the MI; cirrhosis 
of the liver (AST usually elevated more than ALT). 
AST is elevated also in muscular dystrophy, dermato- 
myositis, and paroxysmal myoglobinuria, pancreatitis.
2. Decreased with pyridoxine (vitamin B6) deficiency 
(often as a result of repeated hemodialysis), renal in­
sufficiency, pregnancy, diabetic ketoacidosis, and be­
riberi.
Amylase (a-amylase) 
16-30 g/l*h
Amylase helps to digest starch and glycogen in the 
mouth, stomach, and intestine. Normally, small 
amounts of amylase, originating in the pancreas and 
salivary glands, are present in the blood. Inflammatory 
disease of these glands or obstruction of their ducts re­
sults in regurgitation of large amounts of enzyme into 
the blood and increased excretion via the kidney.
1. Elevated in acute and chronic pancreatitis, pseudo­
cyst of the pancreas, obstruction of pancreatic ducts 
(carcinoma, stone, stricture, duct sphincter spasm after 
morphine), and acute parotitis (mumps). Occasionally 
elevated in renal insufficiency, in diabetic acidosis, 
and in inflammation of the pancreas from a perforating 
peptic ulcer.
2. Decreased in acute and chronic hepatitis, in pan­
creatic insufficiency, and occasionally, in toxemia of 
pregnancy.
Albumin 
35-52 g/1
Albumin is the major plasma protein and is 
synthesized by the liver. It accounts for about 50 % of 
the total hepatic protein production. Albumin has a 
biological half-life in plasma of about 20 days. 
Albumin makes the biggest contribution to the plasma 
oncotic pressure. If the albumin concentration falls 
very low oedema is the result.
1. Elevated in dehydration, shock, hemoconcentration, 
and administration of large quantities of concentrated 
albumin "solution" intravenously.
2. Decreased in acute or chronic glomerulonephritis, 
nephrosis, acute or chronic hepatic insufficiency, 
neoplastic disease, leukemia, nephrotic syndrome, al­
coholic cirrhosis, inflammatory bowel disease, metas­
tatic cancer, Hodgkin’s disease.
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There are three main reasons for the occurrence of a 
low plasma albumin concentration:
Decreased .synthesis. This may be due to malnutrition 
or malabsorption. Decreased synthesis is also a feature 
of advanced chronic liver disease.
Abnormal distribution or dilution. Hypoalbuminaemia 
can be induced hy overhydration or if there is 
increased capillary permeability as occurs in 
septicaemia.
Abnormal excretion or degradation. The causes in­
clude the nephrotic syndrome, protein-losing enteropa­
thies, bums, haemorrhage and calabolic states.
Total protein 
65-85 g/1
The concentration of protein in plasma is influenced 
by the nutritional state, hepatic function, renal func­
tion, occurrence of disease such as multiple myeloma, 
and metabolic errors.
1. Increased levels of total protein observed in cases 
of dehydration. An increase in total protein concentra­
tion in a serum specimen is usually due to an increase 
in the globulin fraction and may indicate the presence 
of a paraprotein.
2. Decreased levels of total protein are usually due to 
hypoalbuminemia. Measurement o f a number of spe­
cific proteins gives useful information in the diagnosis 
and management of disease. Characteristic changes in 
the concentration of certain plasma proteins are seen 
following surgery or trauma, or during infection or 
tumour growth. The proteins involved are called acute 
phase reactants. These acute phase proteins may be 
used to monitor progress of the condition or its treat­
ment.
Fraction of plasma 
proteins:
Albumins 
- 53-66 %
(see albumin above)
Globulins:
20-30 g/L
Globulins constitute several proteins that are separated 
into 4 distinct bands (a l, a2, p and y) on electrophore­
sis.
1. Elevated in hepatic disease, infectious hepatitis, 
cirrhosis o f the liver, biliary cirrhosis, and hemochro­
matosis; disseminated lupus erythematosus; plasma 
cell myeloma; lymphoproliferative disease; sarcoido­
sis; and acute or chronic infectious diseases, particular-
12
ly lymphogranuloma venereum, typhus, leishmaniasis, 
schistosomiasis, and malaria.
2. Decreased in malnutrition, congenital agammaglo­
bulinemia, acquired hypogammaglobulinemia, and 
lymphatic leukemia.
а! - 2-5.5 % al-Antitrypsin is a protease inhibitor with a normal 
concentration of about 200mg/dl. It inhibits trypsin, 
elastase, and certain other proteases by forming com­
plexes with them. It is synthesized in the liver. A defi­
ciency of this protein has a role in certain cases (ap­
proximately 5%) of emphysema and in one type of cir­
rhosis.
а 2 - 6-12 % Haptoglobin (Hp) plasma concentration is increased in 
several inflammatory conditions. The levels of Hp in 
human plasma vary and are of some diagnostic use. 
Low levels of Hp are found in patients with hemolytic 
anemias. Hp binds with the free hemoglobin that spills 
into the plasma due to hemolysis. The haptoglobin- 
hemoglobin complex cannot pass through glomeruli of 
kidney. Hp, therefore, prevents the loss of free Hb into 
urine.
Ceruloplasmin, an oxidase enzyme with a blue color, 
binds to about 95% of serum copper. In Wilson's dis­
ease, serum copper and Ceruloplasmin are low and 
urinary copper is high. Elevated in pregnancy, hyper­
thyroidism, infection, aplastic anemia, acute leukemia. 
Hodgkin's disease, cirrhosis of the liver, and with use 
of oral contraceptives. Decreased in Wilson's disease 
(accompanied by increased urinary excretion of cop­
per), malabsorption, nephrosis, and copper deficiency 
that may accompany total parenteral nutrition. 
Macroglobulin inhibits protease activity and serves as 
an anticoagulant. Its concentration in plasma is ele­
vated in nephrotic syndrome.____________
р - 8-15 % Iron is transported as a complex of the metal-binding 
globulin transferrin (siderophilin). Normally, this 
transport protein carries an amount of iron that repre­
sents about 30-40% of its capacity to combine with 
iron.
Interpretation of Saturation of Transferrin:
1. Elevated in iron excess (iron poisoning, hemolytic 
disease, thalassemia, hemocnromatosis, pyridoxine de-
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ficiency, nephrosis, and, occasionally, hepatitis).
2. Decreased in iron deficiency, chronic infection, 
cancer, and late pregnancy.
у - 11-22% There are five classes of immunoglobulins - namely 
IgG, IgA, IgM, IgD and IgE - containing the heavy 
and light chains.
1. Elevated in liver diseases, persistent infections, sys­
temic lupus erythematosus, myeloma, and lymphoma.
2. Decreased in chronic lymphatic leukemia, acquired 
immunodeficiency syndrome.
Total bilirubin 
3.5-20.5 pmol/1
Destruction of hemoglobin yields bilirubin, which is 
conjugated in the liver to the diglucuronide and ex­
creted in the bile. Bilirubin accumulates in the plasma 
when liver insufficiency exists, biliary obstruction is 
present, or the rate of hemolysis increases. Rarely, ab­
normalities of enzyme systems involved in bilirubin 
metabolism in the liver (eg, absence of glucuronyl 
transferase) result in abnormal bilirubin concentra­
tions.
Total bilirubin can be significantly elevated in normal 
and jaundiced subjects by fasting 24-48 hours (in some 
instances even 12 hours) or by prolonged caloric re­
striction.
Bilirubin conjugated 
(direct bilirubin) 
2.2-5.1 pmol/l
Direct forms of serum bilirubin me elevated in acute or 
chronic hepatitis; biliary tract obstruction (cholangio- 
lar, hepatic, or common ducts); toxic reactions to many 
drugs, chemicals, and toxins; and Dubin- Johnson and 
Rotor's syndromes. Direct can be significantly elevated 
in normal and jaundiced subjects or by prolonged ca­
loric restriction.
Bilirubin unconju­
gated
(indirect bilirubin) 
1.7-17.1 gmol/l
Indirect serum bilirubin is elevated in hemolytic dis­
eases or reactions and absence or deficiency of glu­
curonyl transferase, as in Gilbert's disease and Crigler- 
Najjar syndrome, in acute or chronic hepatitis; biliary 
tract obstruction (cholangiolar, hepatic, or common 
ducts); toxic reactions to many drugs, chemicals, and 
toxins; and Dubin- Johnson and Rotor's syndromes.
Glucose
3.65-6.11 mmol/1
i
The glucose concentration in extracellular fluid is 
normally closely regulated, with the result that a 
source of energy is available to tissues, and no glucose 
is excreted in the urine. Hyperglycemia and hypogly­
cemia are nonspecific signs of abnormal glucose me-
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tabolism.
1. Elevated in diabetes mellitus, hyperthyroidism, 
adrenocortical hyperactivity (cortical excess - Cush­
ing’s syndrome), hyperpituitarism, feochromocytoma, 
pancreas diseases and hepatic disease (occasionally), 
thiazide diuretics.
2. Decreased in hyperinsulinism, adrenal insufficien­
cy, hypopituitarism, hepatic insufficiency (occasional­
ly), functional hypoglycemia, and by hypoglycemic 
agents, malnutrition, sepsis, endocrine tumors.
Creatinine
female - 44-97 pmol/1 
male - 44-115 jimol/1
Creatinine is the anhydride of creatine as a product 
from metabolism in the muscle tissues. Endogenous 
creatinine is excreted by filtration through the glome­
rulus and by tubular secretion. Creatinine clearance is 
an acceptable measure of glomerular filtration rate. 
Creatinine is elevated in acute or chronic renal insuffi­
ciency, urinary tract obstruction, and impairment of 
renal function induced by some drugs. Materials other 
than creatinine may react to give falsely high results 
with the alkaline picrate method (Jaffe reaction): ace- 
toacetate, acetone, p-hydroxybutyrate, a-ketoglutarate, 
pyruvate, glucose, bilirubin, hemoglobin, urea, and 
uric acid. Values below 0.7 mg/dL are of no known 
significance.
Creatine
Phosphokinase (CPK) 
female - 25-175 Ш  
male - 25-200 U/l
CPK splits creatine phosphate in the presence of ADP 
to yield creatine and ATP. Skeletal and heart muscle 
and brain are rich in the enzyme.
1. Elevated in the presence of muscle damage such as 
with myocardial infarction, trauma to muscle, muscu­
lar dystrophies, polymyositis, severe muscular exertion 
(jogging), hypothyroidism, and cerebral infarction 
(necrosis). Following myocardial infarction, serum 
CPK concentration increases rapidly (within 3-5 
hours), and it remains elevated for a shorter time after 
the episode (2 or 3 days) than does AST or LDH.
2. Not elevated in pulmonary infarction or paren­
chymal liver disease.
Creatine Phosphoki­
nase Isoenzymes
CPK consists of 3 proteins separable by electrophore­
sis. Skeletal muscle is characterized by isoenzyme 
MM, myocardium by isoenzyme MB, and brain by 
isoenzyme BB. CPK-ММ is elevated in injury to ske­
letal muscle, myocardial muscle, and brain; in muscle 
disease (eg, dystrophies, hypothyroidism, dermato-
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myositis, polymyositis); in rhabdomyolysis; and after 
severe exercise. CPK-MB is elevated soon (within 2-4 
hours) after myocardial infarction and for up to 72 
hours afterward (high levels are prolonged with 
extension of infarct or new infarction); also elevated in 
extensive rhabdomyolysis or muscle injury, severe 
muscle disease, Reye's syndrome, or Rocky Mountain 
spotted fever. CPK-BB is occasionally elevated in se­
vere shock, in some carcinomas (especially oat cell 
carcinoma or carcinoma of the ovary, breast, or pros­
tate), or in biliary atresia.
y-Glutamyl 
Transpeptidase 
female — 7-32 ил 
male — 11-50 U/l
The microsomal enzyme is present in liver, kidney, 
and pancreas and transfers C-terminal glutamic acid 
from a peptide to other peptides or L-amino acids. It is 
induced by alcohol. Elevated in acute infectious or 
toxic hepatitis, chronic and subacute hepatitis, cirrho­
sis of the liver, intrahepatic or extrahepatic obstruc­
tion, primary or metastatic liver neoplasms, and liver 
damage due to alcoholism. It is elevated occasionally 
in congestive heart failure and rarely in postmyocardi- 
al infarction, pancreatitis, and pancreatic carcinoma.
Lactate dehydrogenase 
(LGH)
225-450 U/l
LDH catalyzes the interconversion of lactate and py­
ruvate in the presence of NADH or NADH2. It is dis­
tributed generally in body cells and fluids and used for 
the diagnosis of myocardial infarction, infective hepa­
titis, leukemia and muscular dystrophy. LDH has five 
isoenzymes. Elevated in all conditions accompanied 
by tissue necrosis, particularly those involving acute 
injury of the heart, red cells, kidney, skeletal muscle, 
liver, lung, and skin. Marked elevations accompany 
hemolytic anemias, the anemias of vitamin B 12 and fo­
late deficiency, and polycythemia rubra vera. The 
course of rise in concentration over 3-4 days followed 
by a slow decline during the following 5-7 days may 
be helpful in confirming the presence of a myocardial 
infarction (increased levels of enzyme takes place after 
8-12 hours after myocardial infarction); however, 
pulmonary infarction, neoplastic disease, and mega­
loblastic anemia must be excluded. Although elevated 
during the acute phase of infectious hepatitis, enzyme 
activity is seldom increased in chronic liver disease. In 
myocardial infarction, the a isoenzymes are elevated - 
particularly LDH 1 to yield a ratio of LDH 1: LDH 2
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of greater than 1. Similar a isoenzyme elevations occur 
in renal cortex infarction and with hemolytic anemias. 
LDH 5 and 4 are relatively increased in the presence of 
acute hepatitis, acute muscle injury, dermatomyositis, 
and muscular dystrophies.
Urea
2.5-8.32 mmol/l
.
Urea, an end product of protein metabolism, is ex­
creted by the kidney. The urea concentration in the 
glomerular filtrate is the same as in the plasma. Tubu­
lar reabsorption of urea varies inversely with rate of 
urine flow. Thus, urea is a less useful measure of 
glomerular filtration than is creatinine, which is not 
reabsorbed. Blood urea nitrogen varies directly with 
protein intake and inversely with the rate of excretion 
of urea.
1. Elevated in 1 )Extra-renal conditions are due to in­
creased nitrogen metabolism associated with dimi­
nished renal blood flow or impaired renal function - 
dehydration (from any cause) and upper gastrointestin­
al bleeding (combination of increased protein absorp­
tion from digestion of blood plus decreased renal 
blood flow), diabetic coma, thyrotoxicosis; 2) Pre- 
renal conditions are due to decreased renal blood flow 
- shock, adrenal insufficiency, diabetes mellitus, dehy­
dration, cardiac failure, etc. ; 3) Renal conditions are 
due to renal insufficiency - nephritis, acute and chron­
ic; acute renal failure (tubular necrosis); 4) Post-renal 
conditions are due to enlargement of prostate, urinary 
tract obstruction, due to tumors, stones, etc.
2. Decreased in hepatic failure, nephrosis not compli­
cated by renal insufficiency, cachexia, pregnancy, 
malnutrition and starvation.
Uric acid 
female -  
0.12-0.34 mmol/l 
male -
0.2-0.415 mmol/l
Uric acid, an end product of purine metabolism, is ex­
creted by the kidney. Gout, a genetically transmitted 
metabolic error, is characterized by an increased plas­
ma or serum uric acid concentration, an increase in to­
tal body uric acid, and deposition of uric acid in tis­
sues. An increase in uric acid concentration in plasma 
and serum may accompany increased purine catabol­
ism (blood dyscrasias, therapy with antileukemic 
drugs), use of thiazide diuretics, or decreased renal ex­
cretion.
1. Elevated in gout, preeclampsia-eclampsia, leuke-
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mia, polycythemia, therapy with antileukemic drugs 
and a variety of other agents, renal insufficiency, gly­
cogen storage disease (type I), Lesch-Nyhan syndrome 
(X-linked hypoxanthine-guanine phosphoribosyl- 
transferase deficit), and Down's syndrome. The inci­
dence of hyperuricemia is greater in Filipinos than in 
whites.
2. Decreased in acute hepatitis (occasionally), treat­
ment with allopurinol, and treatment with probenecid.
Triacylglycerol 
0.5-1.8  mmol/l
Dietary fat is hydrolyzed in the small intestine, ab­
sorbed and resynthesized by the mucosal cells, and se­
creted into lacteals in the form of chylomicrons. Trig­
lycerides in the chylomicrons are cleared from the 
blood by tissue lipoprotein lipase (mainly adipose tis­
sue), and the split products are absorbed and stored. 
Free fatty acids derived mainly from adipose tissue are 
precursors of the endogenous triglycerides produced 
by the liver. Transport of endogenous triglycerides is 
in association with (1-lipoproteins, the very low density 
lipoproteins. In order to ensure measurement of endo­
genous triglycerides, blood must be drawn in the post- 
absorptive state.
1. Elevated (hyperlipoproteinemia) 1) Primary-Type I 
hyperlipoproteinemia (exogenous hyperlipidemia), 
type II hyperbetalipoproteinemia, type III broad beta 
hyperlipoproteinemia, type IV hyperlipoproteinemia 
(endogenous hyperlipidemia), and type V hyperlipo­
proteinemia (mixed hyperlipidemia); 2) Secondary- 
Hypothyroidism, diabetes mellitus, nephrotic syn­
drome, chronic alcoholism with fatty liver, ingestion 
of contraceptive steroids, biliary obstruction, and 
stress.
2. Decreased (hypolipoproteinemia) 1) Primary- 
Tangier disease (a-lipoprotein deficiency), abetalipo- 
proteinemia, and a few rare, poorly defined syn­
dromes; 2) Secondary-Malnutrition, malabsorption, 
and, occasionally, with parenchymal liver disease.
Alkaline phosphatase 
<117 U/l
Alkaline phosphatase is present in high concentration 
in growing bone, in bile, and in the placenta and is 
mainly derived from bone and liver (the cells lining 
the bile canaliculi). In serum, it consists of a mixture 
of isoenzymes. The isoenzymes may be separated by
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electrophoresis; liver alkaline phosphatase migrates 
faster than bone and placental alkaline phosphatase, 
which migrate together. Alkaline phosphatase is useful 
for the diagnosis of rickets, hyperparathyroidism, car­
cinoma of bone, and obstructive jaundice.
1. Elevated in 1) Children (normal growth of bone); 2) 
Osteoblastic bone disease - Hyperparathyroidism, 
rickets and osteomalacia, neoplastic bone disease (os­
teosarcoma, metastatic neoplasms), ossification as in 
myositis ossificans, Paget's disease (osteitis defor­
mans), and Boeck's sarcoid; 3) Hepatic duct or cholan- 
giolar obstruction due to stone, stricture, and neop­
lasm; 4) Hepatic disease resulting from drugs such as 
chlorpromazine and methyltestosterone; 5) Pregnancy.
2. Decreased in hypothyroidism and in growth retar­
dation in children.
Total cholesterol 
3.65-5.2 тто1Л
Cholesterol concentrations sire determined by metabol­
ic functions, which are influenced by heredity, nutri­
tion, endocrine function, and integrity of vital organs 
such as the liver and kidney. Cholesterol metabolism is 
intimately associated with lipid metabolism.
1. Elevated in familial hypercholesterolemia (xantho­
matosis), hypothyroidism, poorly controlled diabetes 
mellitus, nephrotic syndrome, chronic hepatitis, biliary 
cirrhosis, obstructive jaundice, hypoproteinemia (idi­
opathic, with nephrosis or chronic hepatitis), and lipi- 
demia (idiopathic, familial).
2. Decreased in acute hepatitis and Gaucher's disease. 
Occasionally decreased in hyperthyroidism, acute in­
fections, anemia, malnutrition, apolipoprotein defi­
ciency, carcinoma, and acute pancreatitis.
Hemoglobin 
female -120-150 g/1 
male - 130-170 g/1
Hemoglobin is the pigment part of the erythrocyte, and 
the oxygen-carrying part of the blood. A low hemog­
lobin level indicates anemias: posthemorrhagic ane­
mia, iron-deficient anemia, hemodilution.
In urine
Protein, g/1 | Normally only trace amounts of proteins (0,03 g/24 h) 
are present in the urine that are not readily detected. 
When chemically detectable quantities of proteins are 
present in urine, the condition is called as proteinuria. 
Albumin is the major protein present in proteinuria. 
Causes of proteinuria: a) Physiological proteinuria 
(0.5% of protein present) - severe excercise, standing
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for a long time (due to temporary impairment of renal 
circulation), pregnancy, b) Pathological proteinuria: 1) 
Prerenal conditions - dehydration, heart diseases caus­
ing an impaired renal circulation, multiple myeloma, 
etc; 2) Renal conditions - when the lesion is in the kid­
ney as in glomerulamephritis; 3) Post renal conditions 
- lesions of pelvis, bladder, prostate and urethra, in­
flammation of the lower urinary tract, etc.
Glucose, mmol/daily Small amount of glucose (2-20 mg or 0,3-1,1 mmol) 
may be present in fasting urine which cannot be de­
tectable by chemical methods. When glucose is 
present, the condition is called glucosuria. Glycosuria 
occurs in hyperglycaemia with values above renal 
threshold for glucose (7,99-9,99 mmol/l or 160-180 
mg/dl). Glycosuria is the good first line screening test- 
line for diabetes mellitus. Renal glycosuria which is 
caused by a disorder of the renal tubular function. It is 
not accompanied by the classical symptoms of di­
abetes. Alimentary glycosuria: In certain individuals, 
blood glucose level raises rapidly after meals resulting 
in its spill over into urine. It is observed in some nor­
mal people after anesthesia, or emotional stress, and in 
patients of hepatic diseases, hormonal disorders, medi­
cations, pregnancy, hyperthyroidism and peptic ulcer.
Bilirubin It is not present normally in significant amounts since 
it is mainly excreted through bile, unusual amounts of 
bilirubin is detected in urine in cases of obstructive 
jaundice.
Urobilinogen 
0.08-4.23 fimol/daily
Unusual amounts of uribilinogen seen in cases of he­
molytic jaundice.
Amylase (a-amylase) 
28-160 g/l*h (U/L)
In cases of suspected acute pancreatic disease, 
measurement of urine amylase is the most important 
laboratory test. After the onset of acute pancreatitis, 
amylase levels begin to rise within 2 hours, peak with­
in 12 to 48 hours, and return to normal within 3 to 4 
days. Determination of urine levels should follow 
normal serum amylase results to rule out pancreatitis.
Vanillylmandelic acid 
0.7-3.8 mg/daily, 
2.5-38 gmol/daily
Vanillylmandelic acid is the major urinary excretory 
product of both epinephrine and norepinephrine cata­
bolism. Moderately elevated vanillylmandelic acid can 
be caused by a variety of factors such as essential 
hypertension, intense anxiety, intense physical exer-
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cise, and numerous drug interactions (including some 
over-the-counter medications and herbal products), 
pheochromocytoma, neuroblastoma, ganglioma.______
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LESSON 1
Date
THEME: INTRODUCTION TO BIOCHEMISTRY. STRUCTURES OF 
AMINO ACIDS AND PEPTIDES. STRUCTURE, PHYSICO­
CHEMICAL PROPERTIES AND FUNCTIONS OF PROTEINS
The purpose of the lesson: studying of role and problems of biologi­
cal chemistry; familiarizing with features of work in biochemical laboratory, 
with safety rules, application of the international system of units (SI) in bio­
chemical laboratory practice; studying of protein structure and properties: le­
vels and kinds of the macromolecular organization of proteins molecules and 
dependence on their biological properties; familiarizing with qualitative reac­
tions on proteins and amino acids, with reactions of protein sedimentation.
THEORETICAL QUESTIONS:
1. Object and aims of biological chemistry. Most important attributes of liv­
ing matter. Manifestations of dialectic laws in organization and functions 
of living matter.
2. Major divisions and trends in biochemistry. Place of biochemistry among 
other biological subjects. Biochemistry and medicine.
3. Most important stages in the history of biochemistry. Leading native and 
foreign biochemists, their contribution to the development of biochemis­
try. Biochemistry and development of molecular biology, physical-and- 
chemical biology and biotechnology.
4. Proteins as the most important components of the body. Classification 
and functions of the proteins.
5. Structures of amino acids. Classification of amino acids. Role of amino 
acids in organism.
6 . Physico-chemical properties of proteins. Isoelectric point (pi). Molecular 
mass, shape and charge of molecules. The factors determining the solu­
bility of proteins; sedimentation reversible and irreversible. Denaturation 
and renaturation of proteins.
7. Protein structure:
7.1. Primary structure (properties of peptide bonds), secondary structure, 
tertiary structure, quaternary structure.
7.2. Native structure of proteins. Protein structure and functional signi­
ficance. Chaperones, chaperonins.
7.3. The relationship between protein structure and function. Domain 
structure and polymorphism of proteins. Functioning of oligomeric
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proteins (cooperative interaction between protomers). Hemoglobin 
and myoglobin - structure and function. Sickle-cell anemia.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 6 , 7, p. 113.
2. Task from «Clinical Biochemistry» №№ 2, 15, 18, 22, 26, 34, p. 
103,105-109.
LABORATORY WORK:
1) Colour reactions of proteins and amino acids.
Colour reactions are applied to find out the presence of the protein in 
biological fluids, solutions and to establish the amino-acid structure of vari­
ous natural proteins. These reactions are used both for qualitative, and quan­
titative determination of protein and amino acids containing in it.
Reagents: 1. Sodium hydroxide solution, 100 g/L. 2. Copper sulphate 
solution, 10 g/L. 3. Ninhydrin solution, 1 g/L. 4. Nitric acid concentrated. 5. 
Millon's reagent. 6 . Phenol solution, 1 g/L. 7. Solution of egg white for co­
lour reactions.
1. Biuret test on peptide bond.
Proteins in solution answer the biuret reaction, i.e. they develop a 
pink or a purple colour with a solution of dilute copper sulphate and excess of 
NaOH. The colour is due to the presence of at least two peptide bonds. Inso­
luble proteins like keratin and dipeptides do not answer this reaction.
Practical procedure:
Place 5 drops of protein solution in the test-tube. Add 5 drops of 
NaOH solution and add 2 drops o f copper (Il)-sulphate (CuS04) solution 
alongside the test-tube. Red-violet colour is produced.
Write down the results and make a conclusion:____
2. Ninhydrin reaction.
A delicate colour reaction for amino acids is the ninhydrin reaction. 
Most amino acids give a blue or a purple colour on warming with a solution 
of ninhydrin in acetone. Ninhydrin oxidizes the amino acids releasing ammo­
nia. The reduced ninhydrin reacts with the liberated ammonia and another 
molecule of ninhydrin to form the coloured complex. The keto acids formed 
from a amino acids are immediately and quantitatively decomposed to their
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corresponding aldehydes liberating CO2 which is not the case with P and oth­
er amino acids. (Ninhydrin is triketohydrindene hydrate).
Practical procedure:
Place 5 drops of protein solution in the test-tube. Add 5 drops of nin­
hydrin solution and boil 1 -2 minutes. Pink-violet colour or blue-violet colour 
is produced.
Write down the results and make a conclusion:__________________
3. Xanthoproteic reaction.
When a native protein is treated with concentrated HN03, a white 
precipitate (meta protein) is formed and this turns yellow on heating. The yel­
low colour is due to the nitration of the benzene rings of aromatic amino ac­
ids (tryptophan, tyrosine and phenylalanine) of the protein (xantho-yellow).
Practical procedure:
Place 5 drops of protein solution in the test-tube. Add 3 drops of con­
centrated nitric acid. Warm the test-tube carefully, shaking it all the time. So­
lution and precipitate take in yellow colour. Cool the test-tube. Carefully add 
1-3 drops of NaOH solution. Brightly-orange colour is produced.
Write down the results and make a conclusion:_________________
4. Milion's test.
This test is given by the amino acid tyrosine, or any other compound 
containing hydroxyphenyl ring. When a solution of tyrosine is heated with 
Millon's reagent (a solution of mercurous and mercuric nitrates containing 
nitric acid) or 1 0 % mercuric sulphate in 1 0 % H2SO4 and 1 % sodium nitrite, a 
red colour is produced.
Practical procedure:
Place 5 drops of protein solution in the test-tube. Add 3 drops of Mil­
ion s reagent. When white protein precipitate is produced, test-tube need boil. 
The protein precipitate is painted in brick-red colour. To 10 drops of phenol 
solution add 5 drops and carefully to heat up. Pink colour is produced.
Write down the results and make a conclusion:_________________
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2) Reactions of protein sedimentation.
The solubility of proteins is strongly dependent on the salt concentra­
tion (ionic strength) of the medium. Proteins are usually poorly soluble in 
pure water. Their solubility increases as the ionic strength increases, because 
more and more of the well-hydrated inorganic ions (blue circles) are bound to 
the protein's surface, preventing aggregation of the molecules (salting in). At 
very high ionic strengths, the salt withdraws the hydrate water from the pro­
teins and thus leads to aggregation and precipitation of the molecules (salting 
out). For this reason, adding salts such as ammonium sulfate (NFŁ^SC^ 
makes it possible to separate proteins from a mixture according to their de­
gree of solubility (fractionation).
Reagents: 1. Sodium chloride solution. 2. Ammonium sulfate solu­
tion. 3. Salicylsulphonic acid 200 g/L. 4. Trichloroacetic acid 100 g/L. 5. 
Ethanol. 6 . Solution of egg white for sedimentation.
1. Fractional sedimentation of proteins from a sample of blood 
plasma.
Principle of salting-out: This a reverse sedimentation of proteins, by 
adding divalent salts, such as sodium chloride and ammonium sulfate (NH4) 2 
S04 to a sample of blood plasma. This method is used to separate and purify 
proteins and medicines containing globulins for treatment.
Practical procedure:
Step 1. Add 15 drops of proteins sample into 15 drops of saturated 
ammonium sulfate (test-tube 1). 50% saturation is reached - globulins are as 
a precipitate.
Step 2. Filter the sample in 5 min.
Step 3. Wash the filter paper with distilled water (4-5ml) and put it in 
a separate clean test-tube 2 .
Step 4. Add ammonium sulfate powder to the filtrate while it reaches 
full saturation. The precipitant is formed by albumens.
Step 5. Filter the sample in 10 min.
Step 6 . Wash the filter paper with distilled water (4-5ml) and put it in 
a separate clean test-tube 3.
Preserve the solution without proteins for further uses test-tube 4.
Step 7. Then take test-tubes 2, 3, 4 with its contents and carry out the 
biuret test. The positive reaction must be in the test-tubes 2, 3 and the nega­
tive reaction must be in test tube 4.
Write down the results and make a conclusion:_________________
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2. Precipitation of proteins by organic acids.
Practical procedure:
Add 5 drops of proteins solution into each of 2 test-tubes. Add 2 
drops of solution of trichloroacetic acid into the first and add 2  drops of solu­
tion of salicylsulphonic acid into the second of the test-tubes. These reactions 
are used in practical for detecting and separating proteins from solutions. The 
white precipitate indicates the presence of protein.
Write down the results and make a conclusion:
3. Precipitation of proteins by alcohol
Dehydrating agents such as alcohols precipitate the proteins.
Practical procedure:
Add 15-20 drops of alcohol to 5 drops of protein solution into a test- 
tube. A white opalescent appears. You will notice the precipitation of pro­
teins. If distilled water is added into the test tube, opalescent disappears.
Write down the results and make a conclusion:__________________
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, 
p. 4-9.
Literature for essay:
1. D.B. Marks. Biochemistry, 1994, p. 23-32.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 14-50.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 29-81.
Lesson is passed______________________
(The signature o f  the teacher)
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LESSON 2
Date
THEME: STRUCTURE, PHYSICO-CHEMICAL PROPERTIES 
AND FUNCTIONS OF PROTEINS. METHODS OF BIOCHEMICAL
RESEARCH
The purpose of the lesson: studying of physico-chemical and biolog­
ical properties of proteins; studying methods of purification of individual pro­
teins.
Theoretical questions:
1. Ability of proteins to specific interactions.
1.1. Self-organization of polymolecular protein structures.
1.2. The protein-ligand interaction.
1.3. Quantitative determination of proteins.
2. Methods of protein purification.
2.1. Ammonium sulfate precipitation.
2.2. Dialysis.
2.3. Chromatography of proteins (gel filtration chromatography, ion ex­
change chromatography, affinity chromatography).
2.4. Electrophoresis (native PAGE, SDS-PAGE, isoelectric focusing).
QUESTIONS AND EXERCISES:
1. Task from «Clinical Biochemistry» №№ 103, p. 103.
CONTROL TEST «STRUCTURE AND FUNCTIONS OF PROTEINS» 
Main theoretical questions:
1. Structures of 20 amino acids.
2. Isoelectric point (pi).
3. Primary structure of proteins.
4. Secondary structure of proteins.
5. Tertiary structure of proteins.
6 . Quaternary structure of proteins.
7. Ammonium sulfate precipitation.
8 . Dialysis.
9. Chromatography of proteins (gel filtration chromatography, ion ex­
change chromatography, affinity chromatography).
10. Electrophoresis (Native PAGE, SDS-PAGE, isoelectric focusing).
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M AIN LITERATU RE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, 
p. 10-17.
Literature for essay:
1. D.B. Marks. Biochemistry., 1994, p. 27-32.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 14-50.
3. B. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 29-81.
Lesson is passed
(The signature o f the teacher)
LESSON 3
Date
THEME: METHODS OF PROTEIN METABOLISM STUDYING
The purpose of the lesson: studying of clinical significance o f pro­
tein metabolism indexes determination in blood; quantitative methods master­
ing of the blood total protein and albumin determination; learning of analysis 
and clinical interpretation of protein metabolism indexes during pathology.
THEORETICAL QUESTIONS:
1. Sources and ways of protein expenditure in organism: intake, synthesis, 
consumption, excretion. Participation of various organs in protein meta­
bolism: role of gastrointestinal tract, liver, kidneys. Blood proteins de­
fined in laboratory practice: the total proteins, albumins, globulins, en­
zymes.
2. Methods of indicators determination of a protein metabolism in various 
biological liquids. Qualitative reactions and the physical and chemical 
properties of proteins underlying quantitative determination of protein 
metabolism indicators.
3. Clinical significance of total protein determination in blood serum. The 
normal content of the total protein in blood serum in adults and children. 
Absolute and relative hypo-and hyperproteinemia: the reasons, effects.
4. Clinical significance of albumin determination in blood serum. The nor­
mal content of the albumin in blood serum in adults and children. Abso­
lute and relative hypo-and hyperalbuminemia: the reasons, effects.
5. Clinical significance of plasma proteins electrophoretical researches. 
Blood proteins defined electrophoretically, proteinogram, the normal con­
tent of blood proteins various fractions.
6 . Clinical significance of qualitative detection of protein in urine by Gel- 
ler's test.
7. Interpretation of laboratory researches.
LABORATORY WORK:
1. Quantitative determination of total protein by the biuret method in 
the serum.
Principle: Peptide bonds (-CO-NH) of proteins react with cupric ions 
in alkaline medium to form a purple colour complex. The intensity of the 
color is proportional to the total protein concentration.
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Diagnostic significance:
A. Physiologic Basis: Concentration of protein determines colloidal 
osmotic pressure of plasma. The concentration of protein in plasma is influ­
enced by the nutritional state, hepatic function, renal function, occurrence of 
disease such as multiple myeloma, and metabolic errors. Variations in the 
fractions of plasma proteins may signify specific disease.
B. Interpretation:
Increased levels of total protein (hyperproteinemia) observed in 
cases of dehydration. An increase in total protein concentration in a serum 
specimen is usually due to an increase in the globulin fraction and may indi­
cate the presence of a paraprotein.
Decreased levels of total protein (hypoproteinemia) are usually due 
to hypoalbuminemia. Measurement of a number of specific proteins gives 
useful information in the diagnosis and management of disease. Characteris­
tic changes in the concentration of certain plasma proteins are seen following 
surgery or trauma, or during infection or tumour growth. The proteins in­
volved are called acute phase reactants. These acute phase proteins may be 
used to monitor progress of the condition or its treatment.
Total protein, Serum: Normal -  SI: 65-85 g/L, for baby - 56-85 g/L.
Reagents: 1. Biuret reagent (10%NaOH + 1% CuSO4 10:l); 2. Protein 
standard solution; 3. Blood serum.
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette
Test-tube 1 
Test
Test-tube 2 
Standard
Test-tube 3 
Blank
Blood serum 0.02 ml - -
Protein standard solution - 0.02 ml -
Biuret reagent 1.0 ml 1.0 ml 1.0 ml
Add 0.02 ml of researched serum and 1 ml of biuret reagent in a test- 
tube 1 , 0 .0 2  ml of a protein standard solution and 1 .0  ml of biuret reagent in a 
test-tube 2 and 1.0 ml of biuret reagent in a test-tube 3. Mix thoroughly the 
contents of the test-tubes and incubate at a room temperature for 30 minutes 
to let the colors develop. The coloured solutions (test-tubes 1 or 2) are placed 
in cuvettes (the layer thickness=lcm) and analyzed on a photoelectric colo­
rimeter against blank (test-tube 3) at 546 nm wavelength. Determine the opti­
cal densities of standard and test.
Calculation
Determine the concentration of blood protein using the formula:
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C t =  (E t * C s) /  E s,
Where Ct - concentration of the protein in test-tube 1 (Test), Et - opti­
cal density of test in test-tube 1 (Test), Cs - concentration of the protein stan­
dard solution in test-tube 2 (Standard), Es - optical density of standard in test- 
tube 2 (Standard).
Write down the results and make a conclusion:
2. Quantitative determination of albumin by the bromocresol green 
dye in the serum.
Principle: Bromocresol dye reacts with albumin to form an intense 
blue-green coloured complex in succinate buffer (pH 4,2). Intensity of the 
color is proportional to albumin concentration in serum.
Diagnostic significance:
A. Physiologic Basis: Albumin makes the biggest contribution to the 
plasma oncotic pressure. If the albumin concentration falls very low, oedema 
is the result Albumin functions as a transport protein for long-chain fatty ac­
ids, bilirubin, drugs (sulfonamides, penicillin G, dicoumarol, aspirin), and 
some steroid hormones and vitamins. In addition, serum albumin binds Ca2+ 
and Mg2+ ions.
B. Interpretation:
1. Elevated in dehydration, shock, hemoconcentration, and admini­
stration of large quantities of concentrated albumin "solution" intravenously.
2. Decreased in malnutrition, malabsorption syndrome, acute or 
chronic glomerulonephritis, nephrosis, acute or chronic hepatic insufficiency, 
neoplastic disease, leukemia, nephrotic syndrome, alcoholic cirrhosis, in­
flammatory bowel disease, metastatic cancer, Hodgkin’s disease.
There are main reasons for the occurrence of a low plasma albumin 
concentration:
1. Decreased synthesis. This may be due to malnutrition or malab­
sorption. Decreased synthesis is also a feature of advanced chronic liver dis­
ease.
2. Abnormal distribution or dilution. Hypoalbuminaemia can be in­
duced by overhydration or if there is increased capillary permeability as oc­
curs in septicaemia.
3. Abnormal excretion or degradation. The causes include the neph­
rotic syndrome, protein losing enteropathies, bums, haemorrhage and cata­
bolic states.
Albumin, Serum: Normal -  SI: 35-52 g/L.
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Reagents: 1. Bromocresol green reagent; 2. Albumin standard solu­
tion; 3. Blood serum.
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette
Test-tube 1 
Test
Test-tube 2 
Standard
Test-tube 3 
Blank
Blood serum 0.01ml - -
Albumin standard solution - 0.01ml -
Bromocresol green reagent 1.0ml 1.0ml 1.0ml
Add 0.01ml of researched serum and 1 ml of bromocresol green rea­
gent in a test-tube 1 , 0 .0 1 ml of albumin standard solution and 1.0  ml of bro­
mocresol green reagent in a test-tube 2  and 1 .0  ml of bromocresol green in a 
test-tube 3. Mix thoroughly the contents of the test-tubes and incubate at 
37°C for 10 minutes to let the colors develop. The coloured solutions (test- 
tubes 1 or 2 ) are placed in cuvettes (the layer thickness=lcm) and analyzed 
on a photoelectric colorimeter against blank (test-tube 3) at 630-690 nm wa­
velength. Determine the optical densities of standard and test.
Calculation
Determine the concentration of blood albumin using the formula:
Ct = (Et * Cs) / Es,
Where Ct - concentration of the albumin in test-tube 1 (Test), Et - opt­
ical density of test in test-tube 1 (Test), Cs - concentration of the albumin 
standard solution in test-tube 2 (Standard), Es - optical density of standard in 
test-tube 2 (Standard).
Write down the results and make a conclusion:_________________
3. Qualitative determination of protein in urine (Heller test).
Diagnostic significance: Proteinuria - the presence of abnormal 
quantities of protein in the urine. Proteinuria may be a sign of renal (kidney) 
damage. Since serum proteins are readily reabsorbed from urine, the presence 
of excess protein indicates either an insufficiency of absorption or impaired 
filtration. Diabetics may suffer from damaged nephrons and develop 
proteinuria. Conditions causing proteinuria are o f three types: 1) Prerenal 
conditions - dehydration, heart diseases etc.; 2) Renal conditions - all forms
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of renal diseases; 3) Post renal conditions - lesions of pelvis, bladder, prostate 
& urethra etc. With severe proteinuria, general hypoproteinemia can develop 
which results in diminished oncotic pressure. Symptoms of diminished 
oncotic pressure may include ascites, edema, and hydrothorax.
Reagents: 1. Acetic acid solution 10 g/L; 2. Concentrated nitric acid 
with sodium chloride; 3. Urine, containing protein and normal urine.
Heller test. It is necessary to work cautiously at conducting of Heller 
test with the concentrated nitric acid. Place 1 ml of concentrated nitric acid in 
the test-tube by dropper. Then cautiously add equal volume of the filtered 
urine from a pipette to test tube wall so that liquids did not mix up. In case of 
protein presence on border of liquids there is a muddy, whitish ring of a pro­
tein precipitate.
Write down the results and make a conclusion:_________________
MAIN LITERATURE:
1. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., p. 33- 
37.
Lesson is passed________________________
(The signature o f  the teacher)
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LESSON 4
Date
THEME: PROPERTIES OF ENZYMES, COENZYMES AND 
CATALYTIC EFFICIENCY OF ENZYMES. ENZYME KINETICS. 
FACTORS AFFECTING REACTION VELOCITY
The purpose of the lesson: studying of enzymes as biological cata­
lysts, their features, a structure and properties.
THEORETICAL QUESTIONS:
1. History of discovering and studying of enzymes.
2. Specific features of biocatalysts. Substrate and reaction specificity of en­
zymes. Specific features of enzyme separation.
3. The classification and nomenclature of enzymes. Units of enzyme activity 
measurement.
4. Mechanism of enzyme action, "lock and key" and "induced fit models" 
for substrate binding, catalytic efficiency of enzymes.
5. Structural and functional organization of enzymes.
5.1. Simple and complex enzymes.
5.2. Active and allosteric sites, their structures, properties, significance.
5.3. Apoenzyme, cofactor, coenzyme, prosthetic group, holoenzyme.
6. Factors affecting reaction velocity (substrate concentration, pH, tempera­
ture, enzyme concentration). V max and Km of enzymes.
7. Mechanism and stages of enzyme catalysis.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 9, 10 p. 113.
2. Task from «Clinical Biochemistry» №№ 3, p. 103.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005,
p. 18-26.
Literature for essay:
1. D.B. Marks. Biochemistry., 1994, p. 33-35.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 51-61.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 83-101.
Lesson is passed________________________
(The signature o f  the teacher)
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LESSON 5
Date
THEME: ENZYMES. REGULATION OF ENZYMES. ENZYME 
INHIBITION. ENZYMES IN MEDICINE
The purpose of the lesson: considering of regulation mechanisms of 
enzymes activity, change of enzymes activity during diseases, application of 
enzymes in medicine.
THEORETICAL QUESTIONS:
1. Activators and inhibitors of enzymes.
2. Inhibition of enzyme activity, reversible and irreversible inhibition, com­
petitive, noncompetitive inhibition
3. Antimetabolites. Drugs as inhibitors of enzyme activity. Use of inhibitors 
as medicines.
4. Regulation of enzyme activity: allosteric mechanisms, cooperative effects, 
chemical modification, feedback regulation, notion of proenzymes and 
multienzyme complexes.
5. Medical enzymology
5.1. Enzymodiagnostics,
5.2. Enzymotherapy,
5.3. Hereditary enzymopathies.
5.4. The using of tissue-specific enzymes and isoenzymes in laboratory 
diagnostic (lactate dehydrogenase, creatine kinase).
QUESTIONS AND EXERCISES:
Task from «Clinical Biochemistry» №№ 8,12, 38, p. 104-105,110.
LABORATORY WORK:
Amylase (diastase) activity analysis in the serum and urine. 
Diagnostic significance: Normally, very small amylase activity is 
present in urine. But its concentration increases highly in acute pancreatitis, 
pancreatic duct obstruction, and bacterial parotitis. It is elevated in the same 
situations in which the activity of serum amylase is elevated.
Amylase, Serum: Normal -  16-30 g/L h.
A. Physiologic Basis: Normally, small amounts of amylase (dias­
tase), molecular weight about 50,000, originating in the pancreas and salivary 
glands, are present in the blood. Inflammatory disease of these glands or ob-
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struction of their ducts results in regurgitation of large amounts of enzyme 
into the blood and increased excretion via the kidney.
B. Interpretation:
1. Elevated in acute pancreatitis, pseudocyst of the pancreas, obstruc­
tion of pancreatic ducts (carcinoma, stone, stricture, duct sphincter spasm af­
ter morphine), and mumps. Occasionally elevated in renal insufficiency, in 
diabetic acidosis, and in inflammation of the pancreas from a perforating pep­
tic ulcer. Rarely, combination of amylase with an immunoglobulin produces 
elevated serum amylase activity (macroamylasemia) because the large mole­
cular complex (molecular weight at least 160,000) is not filtered by the glo­
merulus.
2. Decreased in acute and chronic hepatitis, in pancreatic insufficien­
cy, and occasionally, in toxemia of pregnancy.
Principle of method: The Caraway method is based on the ability of starch 
solution to change its colour into blue on interaction with iodine solution. 
The intensity of colouring is proportional to the starch concentration in solu­
tion. Amylase activity is determined by decrease the intensity of colouring.
Reagents: 1. Starch solution, 20 g/L; 2. Phosphate-buffer solution,
0.1 mol/L; 3. Sodium chloride solution, 30 g/L; 4. HC1 solution IN; 5. Iodine 
solution 0,01N; 6. Blood serum; 7. Urine.
Procedure:
Take 2 test-tubes as shown in the table below:
Reagents Test, ml Blank, ml
Starch solution 0,5 0,5
Phosphate-buffer solution 0,3 0,3
NaCl 0,1 0,1
HC1 - 0,1
Serum (or Urine) 0,1 0,1
incubate for 30 min at 37UC
HC1 0,1 -
Place into 50 ml flask 0,2 0,2
h 2o 40 40
HC1 0,5 0,5
h 0,1 0,1
h 2o till 50 ml till 50 ml
The solutions are placed in cuvettes (the layer thickness = 1cm) and 
analyzed on a photoelectric colorimeter against distilled water at wavelength 
597±10 nm.
Calculation: The activity of amylase in urine is defined as the num­
ber of starch mg digested by 1 of sample at 37°C in 1 second.
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Amylase activity can be calculated from the following equation:
Ec - Es
Amylase activity, mg/(sec) =------------  • 10 ■ 20 = X,
Ec
Where Ec - optical density of test-tube with control solution, Es - opt­
ical density of test-tube with sample, 10 - starch mass (mg), 20 - coefficient of 
sample dilution.
Write down the results and make a conclusion:_________________
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, 
p. 27-37.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 35-38.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 75-83.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 102-112.
Lesson is passed________________________
(The signature o f  the teacher)
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LESSON 6
Date
COLLOQUEM: PROTEINS. ENZYMES
The purpose of the lesson: knowledge imprinting in memory about
the structure and functions of the proteins and enzymes.
THEORETICAL QUESTIONS:
1. Proteins as the most important components of the body: their functions, 
classification. Shape and size of protein molecules, molecular weight, 
physical and chemical properties.
2. Primary structure of proteins, its role. Hereditary and acquired proteinpa- 
thies. Polymorphism of proteins.
3. Conformation of protein molecule (secondary and tertiary levels). Types 
of intramolecular bonds in protein. Native structure and denaturation of 
proteins. Protein structure and functional significance. Chaperones, chape- 
ronins.
4. Quaternary structure of proteins. Cooperative changes of protomers con­
formation (hemoglobin as compared with myoglobin). Ability of proteins 
to specific interactions. Self-organization of polymolecular protein struc­
tures.
5. Overall scheme and methods of purification of individual proteins and 
characteristics of homogeneity of purified proteins. Quantitative determi­
nation of proteins.
6. Specific features of biocatalysts. Specificity of enzyme effect on the sub­
strate and type of catalytic reaction. Specific features of enzyme separa­
tion. Classification and nomenclature of enzymes.
7. Structural and functional organization of enzymes. Active and allosteric 
centers. Isoenzymes (lactate dehydrogenase, creatine kinase). Mechanism 
and stages of enzyme catalysis. Units of enzyme activity measurement.
8. Effect of substrate and enzyme concentration, temperature and pH on en­
zymatic reaction rate.
9. Regulation of enzyme action: allosteric mechanisms, cooperative effects, 
chemical modification, action based on feedback regulation, notion of 
proenzymes and multienzyme complexes. Examples of metabolic path­
ways regulated by these mechanisms. Physiological significance of en­
zyme action regulation.
10. Activators and inhibitors of enzymes. Use of inhibitors as medicines. An­
timetabolites. Enzymodiagnostics, enzymotherapy, hereditary enzymopa­
thies.
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Q UESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 6,7,9,10 p. 113
2. Task from «Clinical Biochemistry» №№ 1-3,8, 12, 15,18, 22, 26, 
34, 38, p. 103-110.
MAIN LITERATURE:
1 .
2.
Lecture,
Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., p. 4-
37.
Lesson is passed
(The signature o f  the teacher)
LESSON 7
Date
THEME: INTRODUCTION TO METABOLISM. INTRODUCTION IN 
DIGESTION AND ABSORPTION. STRUCTURE AND 
FUNCTIONS OF MEMBRANES
The purpose of the lesson: metabolism studying and its regulation; fa­
miliarizing with processes of food digestion, digestion regulation, absorption of 
the digestion products, biochemical bases of the balanced food; studying struc­
ture and functions of the membranes, types o f transport through membranes.
THEORETICAL QUESTIONS:
1. Characteristics of metabolism.
1.1. Metabolic classification of organism according to sources of energy, re­
ducing power, and starting materials for biosynthesis.
1.2. Metabolism and its functions.
1.3. Regulation of metabolism in the cell.
1.4. Catabolism and anabolism, their integration.
2. Introduction to the biochemistry of digestion.
2.1. Properties of food.
2.2. Digestive enzymes.
2.3. Regulation of digestion with hormones of the gastrointestinal tract.
3. General characteristics and functions of membranes.
3.1. Structure of cell membranes components (lipids, proteins and carbohy­
drates).
3.2. Models of membrane structure.
4. Transmembrane transport.
4.1. Passive transport (simple diffusion, facilitated diffusion).
4.2. Active transport (primary active transport, secondary active transport).
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 1-5, 11-22, 100, 101, p. 
114-115,127.
2. Task from «Clinical Biochemistry» №№ 10, p. 104.
40
M A IN  LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, 
p. 38-58.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 1-4,185-189.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 131- 
142, 406-424,459-466.
3. D. Hames andN. M. Hooper. Biochemistry, 2005, p. 131-155.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 8
Date
THEME: BIOENERGETICS OF THE CELL. ATP FORMATION.
MITOCHONDRIAL ELECTRON TRANSPORT CHAIN
The purpose of the lesson: studying of transfer of protons and electrons
by respiratory chain enzymes.
THEORETICAL QUESTIONS:
1. Bioenergetics general laws of thermodynamics. Endergonic and exergonic 
reactions in metabolism.
2. ATP and other high energy compounds. ADP/ATP cycle. Types of ATP 
phosphorylation (oxidative, substrate and photophosphorylation). Generation 
of ATP from metabolic fuels.
3. Biological oxidation and pathways of oxygen uptake.
4. Tissue respiration. Structure of mitochondria and structural organization of 
electron transport chain. Types of oxygenated substrates.
5. Complete respiratory chain. Mechanism of proton and electron transport. 
NAD (NADP)-linked-dehydrogenases. NADH-dehydrogenase (FMN- 
linked- dehydrogenase). Structure and functions of ubiquinone. Structure 
and functions of cytochromes. Cytochrome oxidase.
6. Incomplete respiratory chain. FAD-linked-dehydrogenases: succinate dehy­
drogenase and acyl-CoA-dehydrogenase.
7. Structural organization of respiratory chain. Respiratory chain complexes.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 33-38, 41, 47-56, 58-62, p.
117-121.
2. Task from «Clinical Biochemistry» №№ 5, 9,14, p. 103-105.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
59-83.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 99-110,116-119.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 92-102.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 372-383.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 9
D ate
THEME: OXIDATIVE PHOSPHORYLATION. OXIDATIVE SYSTEMS 
NOT ASSOCIATED WITH PRODUCTION OF ENERGY
The purpose of the lesson: studying of the oxidative phosphorylation 
and the oxidative systems not connected with production of energy.
THEORETICAL QUESTIONS:
1. Respiratory chain is a key component of the mitochondrial oxidative phos­
phorylation system. Mitochondrial structure and localization of components 
of oxidative phosphorylation system in it. The structural organization of the 
respiratory chain. The mitochondrial electron transport chain as a part of 
respiratory system of all organisms.
2. Oxidative phosphorylation: essence of the process, the generalized scheme, 
substrates, P/О ratio.
3. Hypotheses of the mechanism of oxidative phosphorylation (chemical hy­
pothesis, mechano-chemical hypothesis). The chemiosmotic theory of Mit­
chell.
4. Coupling of oxidation and phosphorylation in the respiratory chain. Trans­
membrane electrochemical potential as the intermediate form of energy at 
oxidative phosphorylation. H-ATP-synthetase: biological role, localization, 
structure, mechanism of ATP synthesis.
5. Inhibitors of oxidative phosphorylation, and uncouplers of oxidative phospho­
rylation and their proposed loci of action.
6. Regulation of functioning of oxidative phosphorylation system. The respi­
ratory control. Infringements of energetic metabolism. Hypoenergetic con­
ditions as result of hypoxia, hypovitaminosis and other reasons.
7. Oxidative systems not associated with energy production. Microsomal oxi­
dation. Free radical oxidation.
8. Active form of oxygen. Formation of reactive oxygen species during bio­
logical oxidation in mitochondria. Physiological and toxic effects of reac­
tive oxygen species. Its role in cell pathology.
QUESTIONS AND EXERCISES:
MSQ from «Clinical Biochemistry» №№ 39, 40, 42-46, 57,63-66, p.
118-122.
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M AIN LITERATU RE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
74-77, 85-81.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, 119-122.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 103-112.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 372-383.
L esson is passed______________________
(The signature of the teacher)
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LESSON 10
Date
COLLOQUIM: INTRODUCTION TO METABOLISM. MEMBRANES. 
BIOLOGICAL OXIDATION AND PATHWAYS OF OXYGEN UPTAKE
The purpose: knowledge imprinting in memory about metabolism, its 
functions and regulation; digestion biochemistry; biological oxidation and tissue 
respiration.
MAIN THEORETICAL QUESTIONS:
1. General characteristics and functions of membranes, membrane components.
2. Models of membrane structure, transmembrane transport.
3. Metabolism and its functions, regulation of metabolism in the cell. Introduc­
tion to the biochemistry of digestion, properties of food, digestive enzymes. 
Regulation of digestion with hormones of the gastrointestinal tract.
4. Catabolism and anabolism, their integration. Endergonic and exergonic reac­
tions in metabolism. ATP and other high energy compounds. ADP/ATP 
cycle. Types of ATP phosphorylation and pathways of APT uptake.
5. Biological oxidation and pathways of oxygen uptake. Structure of mitochon­
dria and structural organization of electron transport chain. Types of oxyge­
nated substrates. NAD-linked dehydrogenases. FAD-linked dehydrogenases: 
succinate dehydrogenase and acyl-CoA-dehydrogenase.
6. NAD-linked dehydrogenases, composition, mechanism of proton and elec­
tron transport.
7. Internal mitochondrial membrane and respiratory chain: NADH-
dehydrogenase, ubiquinone, cytochromes, their structure and mechanism of 
proton and electron transfer to oxygen.
8. Oxidative phosphorylation, P/О ratio. Hypotheses of the oxidative phospho­
rylation mechanism.
9. Coupling of oxidation and phosphorylation in the respiratory chain. H-ATP- 
synthetase. Respiratory control. Uncouplers of oxidative phosphorylation. 
Hypoenergetic conditions.
10.Oxidative systems not associated with energy accumulation. Microsomal 
oxidation. Free radical oxidation. Its role in cell pathology.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 1-5, 11-22, 33-66, 100, 101,
p. 112-122,127.
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2. Task from «Clinical Biochemistry» № №  5, 9, 10 ,1 4 , p. 103-105.
MAIN LITERATURE:
1 .
2 .
Lecture,
Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p.
38-85.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 11
D ate
THEME: CARBOHYDRATE METABOLISM. DIGESTION OF 
DIETARY CARBOHYDRATES. GLUCOSE METABOLISM UNDER 
AEROBIC CONDITION. GLYCOLYSIS
The purpose of the lesson: knowledge imprinting in memory about 
chemistry of carbohydrates, their biological role, considering of glucose catabol­
ism under aerobic and anaerobic conditions, studying of carbohydrate metabol­
ism by oral glucose tolerance test.
THEORETICAL QUESTIONS:
1. Major carbohydrates of human tissues, their biological role.
2. Digestion and absorption of carbohydrates in digestive tract, characteristics 
of enzymes.
3. Scheme of sources and pathways of glucose uptake in the body. Key role of 
glucose-6-phosphate.
4. Glucose metabolism under aerobic condition: sequence of reactions, physio­
logical significance. Energetic and regulation of glycolysis.
5. Shuttle mechanisms of reductive equivalent transfer: glycerol phosphate 
shuttle and malate-aspartate shuttle.
6. Anaerobic glycolysis: sequence of reactions, physiological significance. Cen­
tral oxidation-reduction reaction of glycolysis. Energetic of glycolysis.
7. Alcoholic fermentation. Ethanol metabolism in the body.
8. Oxidative decarboxylation of pyruvate: composition of pyruvate dehydroge­
nase complex and sequence of reactions.
9. Citric acid cycle: sequence of reactions and characteristics of enzymes, regu­
lation. Biological role of CAC.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 67-81,83, 85, 94, 97, 
p.122-127.
2. Task from «Clinical Biochemistry» №№ 29, p. 108.
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LA B O R A TO R Y  W ORK:
Oral glucose tolerance test (OGTT).
WHO recommendation on the retention of the OGTT as a diagnostic 
test: it should be used in individuals who have fasting venous plasma glucose of 
6.1-6.9 mmol/1, to determine glucose tolerance status. The test reveals how 
quickly glucose is metabolized from the bloodstream for use by cells as an ener­
gy source. The test can be used to diagnose diabetes, or prediabetes (a condition 
characterized by higher-than-normal blood sugar levels that can lead to type 2 
diabetes).
With an oral glucose tolerance test, the person fasts overnight. Then first, 
the fasting plasma glucose is tested. After this test, the person receives 75 grams 
of glucose. Usually, the glucose is in a 300 ml of sweet-tasting liquid that the 
person drinks within 5 minutes. Blood samples are taken at specific intervals to 
measure the blood glucose. Plasma glucose levels are measured every 30 mi­
nutes for 3 hours. Some physicians simply get a baseline blood sample followed 
by a sample two hours after drinking the glucose solution.
In a person without diabetes, the glucose levels in the blood rise follow­
ing drinking the glucose drink. Normally, blood glucose levels peak within an 
hour. Then they fall quickly back to normal (because insulin is produced in re­
sponse to the glucose, and the insulin has a normal effect of lowing blood glu­
cose.). Normal response: A person is said to have a normal response when the 2- 
hour glucose level is less than 6.1-7.8 mmol/1 (110 - 140 mg/dl), and all values 
between 0 and 2 hours are less than 11.1 mmol/1 (200 mg/dl).
In a diabetic, glucose levels rise higher than normal after drinking the 
glucose drink and come down to normal levels much slower (insulin is either not 
produced, or it is produced but the cells of the body do not respond to it).
Diabetes: A person has diabetes when two diagnostic tests done on 
different days show that the blood glucose level is high. A person has diabetes 
when oral glucose tolerance tests show that the blood glucose fasting level at or 
above 7.0 mmol/1 (126 mg/dl). Levels between this and 11.1 mmol/1 (200 mg/dl) 
indicate "impaired glucose tolerance. Glucose levels above 11.1 mmol/1 (200 
mg/dl) at 2 hours confirms a diagnosis of diabetes.
1999 WHO Diabetes criteria - Interpretation o f Oral Glucose Tolerance Test
Glucose
levels NORMAL
impaired fasting 
glycaemia (IFG)
impaired glucose 
tolerance (IGT)
Diabetes Mellitus 
(DM)
Venous
Plasma Fasting 2hrs
Fasting 2hrs Fasting 2hrs Fasting 2hrs
(m m ol/1) <6.1 <7.8 >6.1 & <7.0 <7.8 <7.0 >7.8 >7.0 >11.1
(m g /d l) <110 <140 >110 & <126 <140 <126 >140 >126 >200
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Diagnosis Capillary Blood Venous Plasma Blood plasma
Diabetes Mellitus > 11 > 10 > 11
Impaired glucose tolerance 7 ,8 -1 1 7-10 7,8-11
Normal < 7,8 < 7 < 7 ,8
Normal and diabetic responses to an oral glucose load.
Minutes after ingestion o f 75g glucose
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
86-100,122-126.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 131-141,149-157.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 113-120, 
143-156.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 293-314, 367-371.
Lesson is passed___________________
(The signature o f the teacher)
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LESSON 12
Date
THEME: CARBOHYDRATE METABOLISM. GLUCONEOGENESIS. 
PENTOSE PHOSPHATE PATHWAY. GLYCOGEN METABOLISM 
METABOLISM OF FRUCTOSE AND GALACTOSE
The purpose of the lesson: knowledge imprinting in memory about glu­
cose catabolism and glucose synthesis; considering of regulation mechanisms of 
carbohydrate metabohsm under normal and pathological states; mastering of co­
lorimetric dinitrophenylhydrazine method of lactate dehydrogenase activity.
THEORETICAL QUESTIONS:
1. Glucose biosynthesis (gluconeogenesis), physiological function. Glucose- 
lactate cycle (Cori cycle).
2. Pentose phosphate pathway of glucose metabohsm: sequence of reactions, 
biological role.
3. Biosynthesis and glycogen degradation: sequence of reactions.
4. Physiological significance of biosynthesis and glycogen degradation. Regu­
lation of glycogen phosphorylase and synthase activity. Glycogenosises and 
aglycogenosises.
5. Metabolism of fructose and galactose.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 82, 84, 86-93, 95, 96, p. 
124-126.
2. Task from «Clinical Biochemistry» №№ 21, p. 107.
LABORATORY WORK:
Lactate dehydrogenase activity analysis in blood serum by colorime­
tric dinitrophenylhydrazine method according to Sevel and Tovarek.
Principle: The LDH activity is measured by colorimetric method, be­
cause LDH can catalysis lactate to form pyruvate which is able to combine 2,4- 
dinitrophenylhydrazine to produce pyruvate - clinitrophenylhydrazone that is 
shown brownish red in the basic solution.
Diagnostic significance:
A. Physiologic Basis: LDH catalyzes the interconversion of lactate and 
pyruvate in the presence of NADH or NADH2. It is distributed generally in body
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cells and fluids. LDH consists of 5 separable proteins, each made of tetramers of 
2 types, or subunits, H and M. The 5 isoenzymes can be distinguished by kinet­
ics, electrophoresis, chromatography, and immunologic characteristics. By elec­
trophoretic separation, the mobility of the isoenzymes corresponds to serum pro­
teins а ь a2, P, Yi; and y2. These are usually numbered 1 (fastest moving), 2, 3, 4, 
and 5 (slowest moving). Isoenzyme 1 is present in high concentrations in heart 
muscle (tetramer H H H H) and in erythrocytes and kidney cortex; isoenzyme 5 
in skeletal muscle (tetramer M M M M )  and liver.
B. Interpretation:
Elevated in all conditions accompanied by tissue necrosis, particularly 
those involving acute injury of the heart, red cells, kidney, skeletal muscle, liver, 
lung, and skin. Marked elevations accompany hemolytic anemias, the anemias 
of vitamin В i2 and folate deficiency, and polycythemia rubra vera. The course of 
rise in concentration over 3-4 days followed by a slow decline during the fol­
lowing 5-7 days may be helpful in confirming the presence of a myocardial in­
farction (increased levels of enzyme takes place after 8-12 hours after myocardi­
al infarction); however, pulmonary infarction, neoplastic disease, and megalob­
lastic anemia must be excluded. Although elevated during the acute phase of in­
fectious hepatitis, enzyme activity is seldom increased in chronic liver disease. 
In myocardial infarction, the a isoenzymes are elevated - particularly LDH 1 to 
yield a ratio of LDH 1: LDH 2 of greater than 1. Similar a isoenzyme elevations 
occur in renal cortex infarction and with hemolytic anemias. LDH 5 and 4 are 
relatively increased in the presence of acute hepatitis, acute muscle injury, der- 
matomyositis, and muscular dystrophies.
Lactate dehydrogenase, Serum -  Normal: 225-450 U/L.
Practical procedure:
0,1ml of blood diluted 1:2 is added into 0.3 ml NAD solution and then 
incubated at 37°C for 5 min. After both 0.8 ml of sodium pyrophosphate 
(Na4P2O7»1 0 H2O) and 0.2 ml of sodium pyruvate are added, mixed and incu­
bated at 37 °C for 15 min. After 0.5 ml of 2,4-dinitrophenylhydrazine is added 
into above reaction system, mixed and incubated at room temperature for 20 
min. Then 5 ml of sodium hydroxide is added, mixed and incubated at room 
temperature for 10 min. Absorbance (A) value is measured at 500-560 nm with 
the spectrophotometer. Measurement control samples are performed like test 
samples but blood diluted 1:2 is added after incubation.
Calculate enzyme activity according to calibrating graph. For construc­
tion of calibrating graph, it is necessary prepare number of dilutions from so­
dium pyruvate standard according to table:
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Sodium pyru­
vate standard
Sodium pyro­
phosphate
Distilled
water
Pyruvate in stan­
dard sample
Activity o f  pyruvate in 1L 
o f serum for 1 hour o f 
incubation
(ml) (ml) (ml) gg pmol mmol
0,1 0,8 0,5 0,88 0,01 1,2
0,2 0,8 0,4 1,76 0,02 2,4
0,4 0,8 0,2 3,52 0,04 4,8
0,6 0,8 - 5,28 0,06 7,2
0,8 0,6 - 7,04 0,08 9,6
After 0.5 ml of 2,4-dinitrophenylhydrazine is added into test tubes, 
mixed and incubated at room temperature for 20 min. Then 5 ml of sodium hy­
droxide is added, mixed and incubated at room temperature for 10 min. Absor­
bance (A) value is measured at 500-560 nm with the spectrophotometer. Mea­
surement control samples are performed like standard samples but distilled wa­
ter is instead of standard solution.
Write down values of enzyme activity on axes of abscises at construction of ca­
librating graph.
Optical 
density 1
0,5
1,2 2,4 4,8 7 ,2  9,6  Activity of LDH,
mmol/l/(h-l)
Conclusion:
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
101- 121.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, 142-149,157-174.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p.
157-183.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 315-334.
Lesson is passed
(The signature o f  the teacher)
LESSON 13
Date
THEME: METHODS OF CARBOHYDRATE METABOLISM 
STUDYING
The purpose of the lesson: studying of clinical value of carbohydrate 
metabolism indexes determination in blood and urine; mastering of quantitative 
and qualitative methods of glucose determination in blood and urine; learning of 
analysis and clinical interpretation of carbohydrate metabolism indexes during 
pathology.
THEORETICAL QUESTIONS:
1. Sources and pathways of blood glucose uptake. Role of gastrointestinal tract, 
pancreas, liver, kidneys in carbohydrate metabolism.
2. The normal content of glucose in blood. The clinical importance of glucose 
determination in blood. Insulin and extrainsulin hypoglycemias. Hypoglyce­
mia, the reasons, symptoms.
3. The normal content of glucose in urine. The clinical importance of glucose 
determination in urine. A renal threshold of glucose. The reasons and types 
of glucosuria.
LABORATORY WORK:
1. Quantitative determination of glucose by enzymatic method in the
serum.
Principle: Glucose gets oxidized by glucose oxidase to gluconic acid 
and hydrogen peroxide. The enzyme peroxidase converts hydrogen peroxide to 
water and oxygen. The oxygen in turn reacts with 4- amino antipyrine in the 
presence of phenol to form a red coloured complex. Concentration of coloured 
product is measured on photoelectric colorimeter. The intensity of the color is 
proportional to the glucose concentration in solution.
G lu c o s e  o x id a se
Glucose + H20  + 0 2------------ ■—> gluconic acid + H20 2
P e r o x id a s e
H20 2+ phenol + 4- amino antipyrine-------------►dyed complex (red coloured)
Reagents: 1. Glucose reagent; 2. Glucose standard solution; 3. Blood serum.
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Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette
Test-tube 1 
Test
Test-tube 2 
Standard
Test-tube 3 
Blank
Blood serum 0.01 ml - -
Glucose standard solution - 0.01 ml -
Glucose reagent 1.0 ml 1.0 ml 1.0 ml
Add 0.01ml of researched serum and 1 ml of glucose reagent in a test- 
tube 1, 0.01ml of glucose standard solution and 1.0 ml of glucose reagent in a 
test-tube 2 and 1.0 ml of glucose reagent in a test-tube 3. Mix thoroughly the 
contents of the test-tubes and incubate at 37°C for 15 minutes to let the colors 
develop. The coloured solutions (test-tubes 1 or 2) are placed in cuvettes (the 
layer thickness=lcm) and analyzed on a photoelectric colorimeter against blank 
(test-tube 3) at 500 nm wavelength. Determine the optical densities of standard 
and test.
Calculation
Determine the concentration of blood glucose using the formula:
Ct = (Et * Cs) / Es,
Where Ct - concentration of the glucose in test-tube 1 (Test), Et - optical 
density of test in test-tube 1 (Test), Cs - concentration of the glucose standard 
solution in test-tube 2 (Standard), Es - optical density of standard in test-tube 2 
(Standard).
Write down the results and make a conclusion:___________________
Glucose, Serum: Normal -  3.65-6.11 mmol/L or 65-110 mg/dL.
Diagnostic significance:
A. Physiologic Basis: The glucose concentration in extracellular fluid is 
normally closely regulated, with the result that a source of energy is available to 
tissues, and no glucose is excreted in the urine. Hyperglycemia and hypoglyce­
mia are nonspecific signs of abnormal glucose metabolism.
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В. Interpretation:
1. Elevated in diabetes mellitus, hyperthyroidism, adrenocortical hyper­
activity (cortical excess - Cushing’s syndrome), hyperpituitarism, feochromocy- 
toma, pancreas diseases and hepatic disease (occasionally), thiazide diuretics.
2. Decreased in hyperinsulinism, adrenal insufficiency, hypopituitarism, 
hepatic insufficiency (occasionally), functional hypoglycemia, and by hypogly­
cemic agents, malnutrition, sepsis, endocrine tumors.
2. Qualitative determination of sugar in urine (reaction of Nilander).
Principle: The Nilander's reagent containing bismuth nitrate for qualit­
ative detection of sugar in urine is used. Bismuth oxide hydrate in the alkaline 
medium is produced, which is reduced by glucose to the bismuth tincturing a 
liquid in black-brown colour.
Reaction according to Nilander is used specifically for sugar detection 
in urine since bismuth nitrate is not reduced by uric acid (a normal component 
of urine).
Reagents: 1. Urine 1; 2. Urine 2; 3. The Nilander's reagent.
Practical procedure:
Prepare 2 test tubes as shown in the table below:
Pipette Test-tube 1 Test-tube2
Urine 1 20 drops -
Urine 2 - 20 drops
The Nilander's reagent 20 drops 20 drops
Add 20 drops o f Urine 1 and 20 drops of the Nilander’s reagent in the 
test-tube 1. Then add 20 drops of Urine 2 and 20 drops of the Nilander's reagent 
in the test-tube 2. Boil two test-tubes 1 -2 minutes.
Write down the results and make a conclusion:_____________________
Diagnostic significance: Glucose is normally not present in urine. Small 
amount of glucose (2-20 mg or 0,3-1,1 mmol) may be present in fasting urine 
which cannot be detectable by chemical methods. Condition of presence of 
chemically detectable quantities of glucose in urine is called as glycosuria. Gly­
cosuria occurs in hyperglycaemia with values above renal threshold for glucose 
(7,99-9,99 mmol/1 or 160-180 mg/dl). Glycosuria is the good first line screening 
test-line for diabetes mellitus.
Renal glycosuria: Renal glycosuria is a benign condition due to a re­
duced renal threshold for glucose. It is unrelated to diabetes and, therefore,
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should not be mistaken as diabetes. Further, it is not accompanied by the clas­
sical symptoms of diabetes.
Alimentary glycosuria: In certain individuals, blood glucose level raises 
rapidly after meals resulting in its spill over into urine. This condition is referred 
to as alimentary glycosuria. It is observed in some normal people, and in pa­
tients of hepatic diseases, hormonal disorders, medications, pregnancy, hyper­
thyroidism and peptic ulcer.
3. Express diagnostics of sugar determination in urine.
Principle: For the express diagnostics of sugar determination in urine 
test-strips «Urotest», «Urotest П» or «Glucotest» are used. Strips are plastic 
strips to which chemically specific reagent pads are affixed. The reagent pads 
react with the sample urine to provide a standardized visible color reaction with­
in 30 seconds. Urine is added to the pads for reaction by dipping the plastic strip 
into the urine and then slowly withdrawing it. Results are obtained by noting the 
presence of a visible color change on the test pad of the strip. Urine testing for 
sugar is not an accurate way to measure how much sugar is in your blood.
Procedure:
Place 5 ml of urine in the pure dry test tubes from all researching samples. Dip a 
strip into a urine sample for 30 seconds.
Write down the results and make a conclusion:____________________ _
MAIN LITERATURE:
1. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
122-126.
Lesson is passed__________________ _
(The signature o f the teacher)
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LESSON 14
Date
COLLOQUJM: CARBOHYDRATE METABOLISM
The purpose of the lesson: knowledge imprinting in memory about the
carbohydrates metabolism, their connection with energy.
MAIN THEORETICAL QUESTIONS:
1. Common and specific pathways of catabolism. Oxidative decarboxylation of 
pyruvate: composition of pyruvate dehydrogenase complex and sequence of 
reactions.
2. Citric acid cycle: sequence of reactions and characteristics of enzymes, regu­
lation. Biological role of CAC.
3. Major carbohydrates of human tissues, their biological role. Digestion of car­
bohydrates, characteristics of enzymes. Scheme of sources and pathways of 
glucose uptake in the body. Key role of glucose-6-phosphate.
4. Sources and pathways of blood glucose uptake. Regulation of blood glucose 
level by insulin, glucagon, epinephrine and glucocorticoids.
5. Glucose metabolism under aerobic condition: sequence of reactions, physio­
logical significance. Shuttle mechanisms of reductive equivalent transfer.
6. Anaerobic glycolysis: sequence of reactions, physiological significance. Cen­
tral oxidation-reduction reaction of glycolysis. Alcoholic fermentation. Etha­
nol metabolism in the body.
7. Glucose biosynthesis (gluconeogenesis), physiological function. Glucose- 
lactate cycle (Cori cycle).
8. Pentose phosphate pathway of glucose metabolism: sequence of reactions, 
biological role.
9. Biosynthesis and glycogen degradation: sequence of reactions, physiological 
significance. Regulation of glycogen phosphorylase and synthase activity. 
Glycogenoses and aglycogenoses.
10. Metabolism of fructose and galactose. Genetic diseases of metabolism of 
fructose and galactose.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 67-97, p. 122-126.
2. Task from «Clinical Biochemistry» №№ 21, 29, p. 107-108.
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M AIN LITERATURE:
Lecture,
Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p.
86-126.
Lesson is passed
(The signature o f the teacher)
LESSON 15
Date
THEME: LIPID METABOLISM. DIGESTION AND ABSORPTION OF 
LIPIDS. LIPOPROTEINS. OXIDATION OF FATTY ACIDS. 
METABOLISM OF EICOSANOIDS
The purpose of the lesson: studying of lipid biological functions, their 
transport, fatty acids oxidation. Mastering of total phospholipid determination 
method in blood.
THEORETICAL QUESTIONS:
1. Major human tissue lipids: fatty acids, triacylglycerols, phospholipids and 
cholesterol. Functions of lipids. Classification. Physiological norms of daily 
lipids intake. The essential components of dietary lipids for the human or­
ganism.
2. Eicosanoids and their role in regulation of metabolism and physiological 
functions.
3. Digestion of dietary fats as hydrolysis of fats under lipases action, necessary 
conditions. Digestion of phosphoacylglycerols and cholesterol esters. Ab­
sorption of lipid products. Role of bile acids. Resynthesis of lipids.
4. Transport blood lipoproteins: characteristics, synthesis, physiological role. 
Classification of lipoproteins by density, electrophoretic mobility, their func­
tions. Structure of blood lipoprotein.
5. The place of lipoprotein formation, features of lipid structure of various li­
poproteins; apolipoproteins, their functions.
6. Lipid transport in the body. Exogenous and endogenous transport of lipids. 
Lipoprotein lipase.
7. Dislipoproteinaemia. Hyperchylomicronaemia. Hypercholesterolaemia.
8. Chemical mechanism of glycerol oxidation and its energy yield.
9. Activation and oxidation of fatty acids: sequence of reactions, physiological 
significance: formation of fatty acylcamitine and it transport into mitochon­
dria, steps of P- oxidation, oxidation of odd chain fatty acids, oxidation of 
unsaturated fatty acids, the energy yield from P-oxidation of saturated and 
unsaturated fatty acids, regulation of p-oxidation.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 102 -137, p.127-132.
2. Task from «Clinical Biochemistry» №№ 11,13, p. 104-105.
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LABORATORY WORK:
Determination of the total phospholipids in blood serum according to 
the content of phosphorus.
Principle of method: Lipoproteins containing phospholipids are precipi­
tated by trichloroacetic acid according to Davis. It is established the mainten­
ance of lipid phosphorus by thermal hydrolysis and destruction of organic sub­
stances of the protein precipitate in the presence of perchloric acid. It is possible 
to know the level of the total phospholipids according to phosphorus concentra­
tion (phosphorus content is 4% of phospholipid molecular weight).
Diagnostic significance:
Increased levels of phospholipids in the blood are associated with 
hyperlipoproteinemias Па и lib types, glycogenosis I type, diabetes, nephrosis, 
chronic nephritis, essential hyperglycemia, obstructive jaundice, post- 
haemorrhagic anemia, renal coma and other pathological conditions.
Decreased levels of phospholipids in the blood are associated with athe­
rosclerosis, anaemia, acute feverish condition, alimentary dystrophy, cachexia, 
acute hepatitis, portal cirrhosis and fatty degeneration of liver, multiple sclero­
sis, and hyperthyroidism.
Normal content of phosphorus in lipids is 1,97-4,68 mmol/l in healthy
adult.
Reagents: 1. Trichloroacetic acid solution, 100 g/L; 2. Perchloric acid 
(cone) solution, 570 g/L; 3. Ammonium molybdate solution, 40 g/L; 4. Ascor­
bic acid solution, 10 g/L; 5. Standard phosphate solution (KH2P 0 4) containing
0.01 mg of phosphorus in 1 ml; 6. Blood serum.
Practical Procedure:
0.2 ml of blood is added into 3 ml of water in the test-tube. Then 3 ml of 
trichloroacetic acid is added (first 1,5 ml -  on drops, shaking test-tube). Wait 1-2 
min. Then centrifuge during 6 minutes at 2000 revolutions per minute before pre­
cipitate is produced. Pour out supernatant and turn up test-tube on filter paper. 
Add 1 ml of perchloric acid (HC104) to precipitate. Warm up test-tube in sandy 
bath (T=+180°C) till mix is decoloured. At once after burning and cooling, add 5 
ml of water, 1 ml of ammonium molybdate solution (shake) and 1 ml of ascorbic 
acid in the test-tube. Add water till 10 ml is made in the test-tube.
In same time prepare 4 test-tubes as shown in the table below:
Pipette Conlrol Standard test- Standard
Standard
test-tube 1 tube 2 test-tube 3 test-tube 4
Perchloric acid (cone.) 0,8 ml 0,8 mi 0,8 ml 0,8 ml
Standard phosphate - 2 ml 2 ml 2 ml
Water 1 5,2 ml 3,2 ml 3,2 ml 3,2 ml
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Ammonium molybdate 1 ml 1 ml 1 ml 1 ml
Ascorbic acid 1 ml 1 ml 1 ml 1m l
Water 2 2 ml 2 ml 2 ml 2 ml
Mix all test-tubes. In 20 minutes samples are placed in cuvettes (the 
layer thickness=10 mm) and analyzed on a photoelectric colorimeter supplied 
with a red light filter. Calculate value of phosphorus using the formula:
Et 0.02 1000 0.03223
------------------------------  = X mol/1,
E st' 0(2
where 0,02 ml - quantity of phosphorus (mg) containing in 2 ml of the standard 
solution; 0,2 - volume of serum (ml); 1000 - 1000 ml of serum; 0,03223 - quan­
tity of the phosphorus in mmol/L.
Write down the results and make a conclusion:____________________
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
127-136.
Literature for essay:
1. D.B. Marks, et al. "Biochemistry", 1994, p. 185-187, 189-190, 199-206, 
212-214.
2. Robert K. Murray et al. Harper's Dlustrated Biochemistry, 2009, p. 184-204, 
212-223.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 335-345, 363-366.
Lesson is passed_______ ____________
(The signature of the teacher)
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LESSON 16
Date
THEME: LIPID METABOLISM. ACETYL-CoA METABOLISM
The purpose of the lesson: studying of the basic ways of Acetyl-CoA 
using: ketogenesis, cholesterol synthesis, fatty acids synthesis; familiarizing 
with qualitative reaction on ketone bodies.
THEORETICAL QUESTIONS:
1. Sources of Acetyl-CoA and pathways where it is used.
2. Metabolism of ketone bodies. Ketogenesis. Oxidation of ketone bodies. Reg­
ulation of ketone bodies utilization. Ketonemia, ketonuria, ketosis.
3. Metabolism and functions of cholesterol. Biosynthesis of cholesterol: se­
quence of reactions, regulation.
4. Biosynthesis of fatty acids: synthesis and role of malonyl-CoA, characteris­
tics of palmitate synthase complex, regulation.
5. Production of long-chain fatty acids and unsaturated fatty acids.
6. Synthesis of triacylglycerols and glycerophospholipids.
7. Major pathological processes associated with disorders of acetyl-CoA meta­
bolism (fasting, obesity, atherosclerosis, cholelithiasis, diabetes).
QUESTIONS AND EXERCISES:
Task from «Clinical Biochemistry» №№ 24, p. 107.
LABORATORY WORK:
Qualitative determination of ketone bodies in urine.
Principle: The method is based on the tendency of acetone and acetoa- 
cetic acid to form, when allowed to react with sodium nitroprusside in an alka­
line medium, complexes coloured orange-red which turn to cherry-red products 
in an acidified medium.
Diagnostic significance:
In normal individuals, there is a constant production of ketone bodies 
by liver and their utilization by extrahepatic tissues. The concentration of ketone 
bodies in blood is maintained around 1 mg/dl. Their excretion in urine is very 
low and undetectable by routine tests. When the rate of synthesis of ketone bo­
dies exceeds the rate of utilization, their concentration in blood increases, this is 
known as ketonemia. This is followed by ketonuria - excretion of ketone bodies 
in urine. The overall picture of ketonemia and ketonuria is commonly referred to
63
as ketosis. Smell of acetone in breath is a common feature in ketosis. Ketosis is 
most commonly associated with starvation and severe uncontrolled diabetes 
mellitus.
Starvation: Starvation is accompanied by increased degradation of fatty 
acids (from the fuel reserve triacylglycerol) to meet the energy needs of the 
body. This causes an overproduction of acetyl-CoA which cannot be fully han­
dled by citric acid cycle. Furthermore, TCA cycle is impaired due to deficiency 
of oxaloacetate, since most of it is diverted for glucose synthesis to meet the es­
sential requirements (often unsuccessful) for tissues like brain. The result is an 
accumulation of acetyl-CoA and its diversion for overproduction of ketone bo­
dies.
Diabetes mellitus: Diabetes mellitus is associated with insulin deficien­
cy. This results in impaired carbohydrate metabolism and increased lipolysis, 
both of them ultimately leading to the accumulation of acetyl-CoA and its con­
version to ketone bodies. In severe diabetes, the ketone body concentration in 
blood plasma may reach 100 mg/dl and the urinary excretion may be as high as 
500 mg/day.
Reagents: 1. Urine; 2. Sodium nitroprusside solution, 100 g/L; 3. Ace­
tate solution; 4. NaOH solution, 100 g/L.
Practical procedure:
Add 1 drop of 10% sodium nitroprusside solution and 2 drops of 10% 
NaOH solution to 5 drops of urine. The orange-red colour is produced. Add 3 
drops of acetate solution. The cherry colour is produced.
Write down the results and make a conclusion:_____________________
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
137-146.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 190-197,206-212,214-217.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 193-204,
224-233.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 346-362.
Lesson is passed____________________
(The signature of the teacher)
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LESSON 17
Date
THEME: ADIPOSE TISSUE. BIOCHEMISTRY OF 
ATHEROSCLEROSIS
The purpose of the lesson: knowledge imprinting in memory about 
structure and biological role of lipids, adipose tissue; studying of cholesterol me­
tabolism and functions, considering of cholesterol transport and biochemical as­
pects of obesity and atherosclerosis development.
THEORETICAL QUESTIONS:
1. Deposition and mobilization of fats in adipose tissue. Regulation. Transport 
and uptake of fatty acids.
2. Obesity. Pathogenesis, classification and adiposity treatment.
3. Metabolism and functions of cholesterol. Direct transport of cholesterol. 
Role of LDL. Reverse transport of cholesterol. Role of HDL and LCAT.
4. Biochemistry of atherosclerosis.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
147-153.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 197-199,217-219.
Lesson is passed___________________
(The signature of the teacher)
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LESSON 18
Date
THEME: METHODS OF PROTEIN AND LIPID 
METABOLISM STUDYING
The purpose of the lesson: studying of the clinical importance of pro­
tein and lipid metabolisms values determination, mastering of the quantitative 
methods of determination of urea, total cholesterol, triacylglycerols and HDL 
cholesterol determination in blood; mastering of the methods of phenyl pyruvate 
qualitative determination and diagnostics of phenylketonuria; mastering of the 
calculation procedure of lipoprotein electrophoregram indexes; learning of anal­
ysis and clinical interpretation of protein and lipid metabolism values at the pa­
thology.
THEORETICAL QUESTIONS:
1. Urea of serum: formation sources, excretion. Role of liver, kidneys in am­
monia detoxification. Normal concentration of urea. Clinical significance of 
urea content change. The reasons, consequences.
2. Sources and ways of cholesterol and triacylglycerols using in organism. Liv­
er role, endocrine systems in lipid metabolism.
3. The normal total cholesterol content in blood. The clinical importance of to­
tal cholesterol determination: hyper-and hypocholesterolemia, the reasons, 
symptoms.
4. The normal triacylglycerols content in blood. The clinical importance of tri­
acylglycerols determination: hyper-and hypotriacylglycerolemia, the rea­
sons, symptoms, consequences.
5. Calculation of the cholesterol-LDL content, atherogenity index. Normal val­
ues. Clinical interpretation of results.
6. The normal content of HDL cholesterol in blood. The clinical importance of 
HDL cholesterol determination: hyper-and hypo-a-cholesterolemia, the rea­
sons, consequences.
7. Lipidogram. Calculation of the LDL cholesterol content, atherogenity index. 
Normal values. Clinical interpretation of results.
8. Electrophoresis of lipoproteins. Classification of the lipoprotein classes ac­
cording to electrophoretical mobility. The changes of blood lipoprotein elec­
trophoregram during various types of hyperlipoproteinemias.
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LA BO RA TO RY  WORK:
Quantitative determination of urea by enzymatic method in the se­
rum.
Principle: Urea in the blood is converted to ammonia and C 0 2 by the 
action of urease enzyme. Ammonia reacts with chromogen in the presence of 
sodium hypochlorite to form coloured complex. Concentration of coloured 
product is measured on photoelectric colorimeter. Concentration of blood urea is 
directly proportional to the colour intensity.
Diagnostic significance:
A. Physiologic Basis: Urea, an end product of protein metabolism, is 
excreted by the kidney. The urea concentration in the glomerular filtrate is the 
same as in the plasma. Tubular reabsorption of urea varies inversely with rate of 
urine flow. Thus, urea is a less useful measure of glomerular filtration than is 
creatinine, which is not reabsorbed. Blood urea nitrogen varies directly with pro­
tein intake and inversely with the rate of excretion of urea.
B. Interpretation:
1. Elevated in
• Extra-renal conditions are due to increased nitrogen metabolism associated 
with diminished renal blood flow or impaired renal function - dehydration 
(from any cause) and upper gastrointestinal bleeding (combination of in­
creased protein absorption from digestion of blood plus decreased renal 
blood flow), diabetic coma, thyrotoxicosis.
• Pre-renal conditions are due to decreased renal blood flow - shock, adrenal 
insufficiency, diabetes mellitus, dehydration, cardiac failure, etc.
• Renal conditions are due to renal insufficiency - nephritis, acute and chronic; 
acute renal failure (tubular necrosis).
• Post-renal conditions are due to enlargement of prostate, urinary tract ob­
struction, due to tumors, stones, etc.
2. Decreased in hepatic failure, nephrosis not complicated by renal in­
sufficiency, cachexia, pregnancy, malnutrition and starvation.
Urea, Seram: Normal -  2,5-8,3 mmoL/l (8-25 mg/dL),
Urea, Urine: 333,0-587,7 mmol/L (21-53 mg/dL).
Reagents: 1. Reagent 1 (enzymatic reagent), Reagent 2 (chromogen), 
Reagent 3 (sodium hypochlorite); 2. Urea standard solution; 3. Blood serum. 
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
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Pipette
Test-tube 1 Test-tube 2 Test-tube 3
Test Standard Blank
Blood serum 0.01ml - -
Urea standard solution - 0.01ml -
Reagent 1 0.25ml 0.25ml 0.25ml
incubation at 37UC for 10 min
Reagent 2 (chromogen) 0.5ml 0.5ml 0.5ml
Reagent 3 (sodium hypochlorite) 0.5ml •0.5ml 0.5ml
incubation at 37°C for 5 min
Add 0.01ml of researched serum and 0.25ml of Reagent 1 in a test-tube 
1, 0.01ml of urea standard solution and 0.25ml of Reagent 1 in a test-tube 2 and
0.25ml of Reagent 1 in a test-tube 3. Mix thoroughly the contents of the test- 
tubes and incubate at 37°C for 10 minutes
After incubation add 0.5 ml of Reagent 2 and Reagent 3 in all test-tubes 
(test- tube 1, test-tube 2, and test-tube 3) sequentially, incubate at 37°C for 5 mi­
nutes. The coloured solutions (test-tubes 1 or 2) are placed in cuvettes (the layer 
thickness=lcm) and analyzed on a photoelectric colorimeter against blank (test- 
tube 3) at 590 nm wavelength. Determine the optical densities of standard and 
test.
Calculation
Determine the concentration of blood urea using the formula:
Ct = (Et * Cs) / Es,
Where Ct - concentration of the urea in test-tube 1 (Test), Et - optical 
density of test in test-tube 1 (Test), Cs - concentration of the urea standard solu­
tion in test-tube 2 (Standard), Es - optical density of standard in test-tube 2 (Stan­
dard).
Write down the results and make a conclusion:____________________
2. Quantitative reaction on phenylpyruvate (Feling's sample).
Principle: Phenylpyruvate reacts with iron ions to form the complex of 
blue-green color.
Diagnostic significance: Phenylketonuria is inherited as an autosomal 
recessive trait (both parents must pass on the defective gene for the child to be 
affected). The genetically-determined abnormality in phenylketonuria is a miss­
ing enzyme called phenylalanine hydroxylase. In PKU, phenylalanine cannot be 
used in a normal fashion because of the missing enzyme. Subsequently, high
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levels of phenylalanine, and 2 closely-related phenylalanine derivatives, build 
up in the body. These compounds are toxic to the central nervous system and 
cause brain damage. Damage to the brain causes marked mental retardation by 
the end of the first year of life if  the offending proteins are not scrupulously 
avoided. Older children may develop movement disorders (athetosis), rocking, 
and hyperactivity. PKU is a treatable disease that can be easily detected by a 
simple blood test. Most states require a screening test for all newborns, generally 
done with a heelstick shortly after birth. Blood is routinely drawn from newborn 
infants for testing. Blood is obtained by "heel stick" and collected on a special 
blotter paper.
Because phenylalanine is involved indirectly in the production of mela­
nin, children with phenylketonuria often have lighter complexions than their un­
affected siblings. There is a characteristic "mousy" odor that results from the ac­
cumulation of phenylacetic acid. This odor may be detected on the breath, skin, 
and urine if the condition has not been treated immediately from birth or if foods 
containing phenylalanine are consumed.
Reagents: 1. Urine 1 and 2; 2. Iron chloride solution; 3. Filter papers.
Practical procedure:
Put several urine drops on 2 filter papers; add 8-10 drops of iron chloride solu­
tion.
Write down the results and make a conclusion:
3. Quantitative determination of total cholesterol by enzymatic me­
thod in the serum.
Principle: Cholesterol is product of cholesterol esters hydrolysis by cho­
lesterol esterase. It is oxidized by air oxygen by cholesterol oxidase. Hydrogen 
peroxide is product of this reaction resulting in chromogenous substrate oxida­
tion catalyzed by peroxidase with pink coloured compounds appearance. The 
intensity of the colour is proportional to the cholesterol concentration in plasma.
C h o le s te r o l e s te ra se
Cholesterol esters + H20  ------------------------ ►Cholesterol + fatty acids
C h o le s te r o l  o x id a s e
Cholesterol + 0 2 ---------------------И -cholestenone + H20 2
P e ro x id a s e
2 H20 2 + chromogenous substrate --------► coloured compound + 2 H20
69
Diagnostic significance: Cholesterol is transported in the blood as a 
component of VLDL and LDL, 60-70% - in a form of cholesterol esters and 30- 
40% - as free cholesterol. Total blood serum cholesterol contains cholesterol and 
its esters. Cholesterol level increases during the life.
A. Physiologic Basis: Cholesterol concentrations are determined by me­
tabolic functions, which are influenced by heredity, nutrition, endocrine func­
tion, and integrity of vital organs such as the liver and kidney. Cholesterol meta­
bolism is intimately associated with lipid metabolism.
B. Interpretation:
1. Elevated in familial hypercholesterolemia (xanthomatosis), hypothy­
roidism, poorly controlled diabetes mellitus, nephrotic syndrome, chronic hepa­
titis, biliary cirrhosis, obstructive jaundice, hypoproteinemia (idiopathic, with 
nephrosis or chronic hepatitis), and lipidemia (idiopathic, familial).
2. Decreased in acute hepatitis and Gaucher's disease. Occasionally de­
creased in hyperthyroidism, acute infections, anemia, malnutrition, apolipo- 
protein deficiency, carcinoma, and acute pancreatitis.
Hypercholesterolemia
Norm -  at the 3.65- 5.2 mmol/L or 140-200 mg/dL
Low risk -  at the 5.2-6.5 mmol/L or 200-250 mg/dL
Moderate risk -  at the 6.5-7.8 mmol/L or 250-300 mg/dL
High risk -  at the greater than 7.8 mmol/L or 300 mg/dL.
Cholesterol, Serum: Normal -  3.65- 5,2 mmol/1 or 140-200 mg/dL.
Reagents: 1. Working reagent 1; 2. Cholesterol standard solution - 5,17 
mmol/L (200mg/100ml); 3. Blood serum.
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette
Test-tube 1 
Test
Test-tube 2 
Standard
Test-tube 3 
Blank
Blood serum 0.01 ml - -
Cholesterol standard solution - 0.01 ml -
Reagent 1 1.0 ml 1.0 ml 1.0 ml
Add 0.01 ml of researched serum and 1 ml of Reagent 1 in a test-tube 1,
0.01 ml of cholesterol standard solution and 1.0 ml of Reagent 1 in a test-tube 2 
and 1.0 ml of Reagent 1 in a test-tube 3.
Mix thoroughly the contents of the test-tubes and incubate at 37°C for 
10 minutes to let the colors develop. The coloured solutions (test-tubes 1 or 2) 
are placed in cuvettes (the layer thickness=lcm) and analyzed on a photoelectric
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colorimeter against blank (test-tube 3) at 500 nm wavelength. Determine the opt­
ical densities of standard and test.
Calculation
Determine the concentration of blood cholesterol using the formula:
Ct = (Et * Cs) / Es,
Where Ct - concentration of the cholesterol in test-tube 1 (Test), Et - opt­
ical density of test in test-tube 1 (Test), Cs - concentration of the cholesterol 
standard solution in test-tube 2 (Standard), Es - optical density of standard in test- 
tube 2 (Standard).
Write down the results and make a conclusion:_____________________
4. Quantitative determination of triacylglycerol by enzymatic method 
in the serum.
Principle: Triacylglycerols are hydrolyzed by the action of lipoprotein 
lipase to glycerol and fatty acids. Glycerol is oxidized by glycerolkinase, af­
ter that by glycerolphosphateoxidase. Hydrogen peroxide is product of this reac­
tion resulting in 4-chlorphenol and 4-aminephenazon oxidation catalyzed by pe­
roxidase with red coloured compounds appearance. The intensity of colouring 
is proportional to the triacylglycerol concentration in plasma.
Diagnostic significance:
A. Physiologic Basis: Dietary fat is hydrolyzed in the small intestine, 
absorbed and resynthesized by the mucosal cells, and secreted into lacteals in 
the form of chylomicrons. Triglycerides in the chylomicrons are cleared from 
the blood by tissue lipoprotein lipase (mainly adipose tissue), and the split prod­
ucts are absorbed and stored. Free fatty acids derived mainly from adipose tissue 
are precursors of the endogenous triglycerides produced by the liver. Transport 
of endogenous triglycerides is in association with (3-lipoproteins, the very low 
density lipoproteins. In order to ensure measurement of endogenous triglyce­
rides, blood must be drawn in the postabsorptive state.
B. Interpretation: Concentration of triglycerides, cholesterol, and lipo­
protein fractions (VLDL, LDL, and HDL) is interpreted collectively. Distur­
bances in normal relationships of these lipid moieties may be primary' or sec­
ondary in origin.
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1. Elevated (hyperlipoproteinemia)-
a. Primary-Type I hyperlipoproteinemia (exogenous hyperlipidemia), 
type II hyperbetalipoproteinemia, type III broad beta hyperlipoproteinemia, type 
IV hyperlipoproteinemia (endogenous hyperlipidemia), and type V hyperlipo­
proteinemia (mixed hyperlipidemia).
b. Secondary-Hypothyroidism, diabetes mellitus, nephrotic syndrome, 
chronic alcoholism with fatty liver, ingestion of contraceptive steroids, biliary 
obstruction, and stress.
2. Decreased (hypolipoproteinemia)-
a. Primary-Tangier disease (a-lipoprotein deficiency), abetalipoprotei- 
nemia, and a few rare, poorly defined syndromes.
b. Secondary-Malnutrition, malabsorption, and, occasionally, with pa­
renchymal liver disease.
Hypertriacylglycerolemia
Norm -  at the 0.5 - 1.8 mmol/L
Low risk -  at the 1.81-2.25 mmol/L
Moderate risk -  at the 2.26-4.50 mmol/L
High risk -  at the greater than 4.50 mmol/L.
Triacylglycerol, Serum: Normal -  0.5 -1.8 mmol/L.
Reagents: 1. Reagent 1; 2. Glycerol standard solution; 3. Blood serum.
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette
Test-tube 1 
Test
Test-tube 2 
Standard
Test-tube 3 
Blank
Blood serum 0.01ml - -
Glycerol standard solution - 0.01ml -
Reagent 1 1.0 ml 1.0 ml 1.0 ml
Add 0.01 ml of researched serum and 1 ml of Reagent 1 in a test-tube 1,
0.01 ml of glycerol standard solution and 1.0 ml of Reagent 1 in a test-tube 2 and 
1.0 ml of Reagent 1 in a test-tube 3.
Mix thoroughly the contents of the test-tubes and incubate at a room 
temperature for 10 minutes to let the colors develop. The coloured solutions 
(test-tubes 1 or 2) are placed in cuvettes (the layer thickness=lcm) and analyzed 
on a photoelectric colorimeter against blank (test-tube 3) at 500 nm wavelength. 
Determine the optical densities of standard and test.
Calculation
Determine the concentration of blood triacylglycerol using the formula: 
Ct = (Et * Cs) / Es,
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Where Ct - concentration of the triacylglycerol in test-tube 1 (Test), Et - 
optical density of test in test-tube 1 (Test), Cs - concentration of the glycerol 
standard solution in test-tube 2 (Standard), Es - optical density of standard in test- 
tube 2 (Standard).
Write down the results and make a conclusion:_________________
5. Calculation of lipid atherogenity (atherogenicity) index according 
to determination of total cholesterol, HDL and triacylglycerol concentra­
tions.
The index of atherogenity (IA) is the ratio between cholesterol of athe­
rogenic lipoprotein classes to cholesterol of antiatherogenic lipoprotein classes:
IA = (Ch(total) — Ch-HDL) / Ch-HDL (absolute units)
The index of atherogenity is used for estimation of a atherosclerosis 
risk degree.
Norm -  up to 3
low risk -  at the 3-4
average risk -  at the 4-5
High risk -  at the greater than 5.
It is necessary to calculate Ch-LDL:
Ch-LDL = Ch(total) -  Ch-HDL -  Ch-VLDL;
Ch-VLDL = TG * 0,458
According to classification of the European society on struggle against an 
atherosclerosis LDL level is divided on:
Normal level LDL - at the 1,91 -2,60 mmol/1; 
easy increasing of LDL level - at the 2,61-3,40 mmol/1; 
moderate increasing of LDL level - at the 3,41-5,05 mmol/1; 
the expressed increase in level LDL > 5,05 mmol/1.
Procedure:
According to a clinical task (the teacher gives) calculate an atherogenity 
index and Ch-LDL concentration.
Write down the results and make a conclusion:
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6. Determination of lipoprotein electrophoretic separation.
Agarose gel electrophoresis with staining for lipids. During this type of 
electrophoresis, the quantity of each lipoprotein class is measured based on its 
movement in an electrical field. Lipoprotein electrophoresis is used for deter­
mination of hyperlipoproteinaemias.
Schematically the arrangement of lipoprotein fractions is shown in the 
picture.
HDL or a-LP
L
VLDL or pre-p-LP
LDL or p-LP ! '
■ i Ш
Start/Chylomicron
Type of hyperlipoproteinaemias Norma 1 Па ПЬ Ш IV V
Lipoprotein electrophoregram of the blood serum is shown:
The fastest are a-lipoproteins 22,3-53,3%, then LP (a) 0% (if they 
present), then pre-P-lipoproteins 4,4-23,1%, then P-lipoproteins 38,6-69,4%; 
chylomicrons remain on start 0% (they are detected only after meal).
Hyperlipidemias are classified according to the Fredrickson 
classification which is based on the pattern of lipoproteins on electrophoresis. 
The six types of hyperlipoproteinaemia are defined in the Fredrickson Classifi­
cation.
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Fredrickson
phenotype Synonyms Defect
LP ab­
nor­
mality
Associated clinical 
disorders
Ch TG
Type I 
(rare)
Primary
hyperlipo-
proteinaemia, or
Familial
hyperchy-
lomicronemia
Decreased 
lipoprotein 
lipase or al­
tered ApoC2
Chylo­
microns
Diabetes, lupus, dysglobuli- 
nemia
i i
Type Па Polygenic hyper- 
cholesterolaemia 
or Familial hyper­
cholesterolemia
LDL receptor 
deficiency
LDL Nephrosis, hypothyroidism, 
myxedema, dysgammaglo- 
bulinemia, obstructive liver 
disease acute intermittent 
porphyria
t r —♦
Type Hb Combined
hyperlipidemia
Decreased 
LDL receptor 
and Increased 
ApoB
LDL and 
VLDL
Myxedema, dysgammaglo- 
bulmemia, obstructive liver 
disease acute intermittent 
porphyria
tt t
Type Ш 
rare)
Familial
dysbetalipoprote-
in-emia
Defect in Apo 
E2 synthesis
EDL myxedema, dysgammaglo- 
bulinemia
t t
Type IV Familial
hyperlipemia
Increased 
VLDL produc­
tion and De­
creased elimi­
nation
VLDL diabetes, corticosteroid 
therapy, acute alcohol intox­
ication, acute pancreatitis, 
gout, gram-negative sepsis, 
glycogen storage disease I, 
oral contraceptive use, 
nephrotic syndrome, chronic 
renal failure, obesity.
-* t r T
Type V 
rare)
Endogenous
hypertriglycerid­
emia
Increased 
VLDL produc­
tion and De­
creased LPL
Chylo­
microns
and
VLDL
Diabetes, nephrotic syn­
drome, acute alcohol intoxi­
cation, myeloma disease
r
Hyperlipoproteinemia type I  is a form of hyperlipoproteinemia asso­
ciated with deficiencies of lipoprotein lipase.
Hyperlipoproteinemia type П, by far the most common form, is further 
classified into type Па and type lib, depending mainly on whether there is 
elevation in the triglyceride level in addition to LDL cholesterol.
Type Ha: This may be sporadic (due to dietary factors), polygenic, or 
truly familial as a result of a mutation either in the LDL receptor gene on 
chromosome 19 (0.2% of the population) or the ApoB gene (0.2%). The familial 
form is characterized by tendon xanthoma, xanthelasma and premature 
cardiovascular disease. The incidence of this disease is about 1 in 500 for 
heterozygotes, and 1 in 1,000,000 for homozygotes.
T^pe Hb: The high VLDL levels are due to overproduction of 
substrates, including triglycerides, acetyl CoA, and an increase in B-100 
synthesis. They may also be caused by the decreased clearance of LDL. 
Prevalence in the population is 10%.
Hyperlipoproteinemia type Ш: This form is due to high chylomicrons 
and IDL. Also known as broad beta disease or dysbetalipoproteinemia, the most
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common cause for this form is the presence of ApoE E2/E2 genotype. It is due 
to cholesterol-rich VLDL (P-VLDL). Prevalence is 0.02% of the population.
Hyperlipoproteinemia type IV (type 4 = familial): This form is due to 
high triglycerides. It is also known as hypertriglyceridemia (or pure hypertrigly­
ceridemia). According to the NCEP-АТРШ determination of high triglycerides 
(>200 mg/dl), prevalence is about 16% of adult population.
Hyperlipoproteinemia type V (type 5 = endogenous): This type is 
very similar to type I, but with high VLDL in addition to chylomicrons. It is also 
associated with glucose intolerance and hyperuremia.
Procedure:
On electrophoregram (a clinical task the teacher gives) define the basic 
classes of lipoproteins and what type of hyperlipoproteinaemias in each sample.
Write down the results and make a conclusion:_____________________
MAIN LITERATURE:
1. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
147-153.
Lesson is passed___________________
(The signature of the teacher)
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LESSON 19
Date
THEME: DIGESTION OF PROTEINS. METABOLISM AND 
FUNCTIONS OF AMINO ACIDS. TRANSAMINATION. 
DEAMINATION
The purpose of the lesson: knowledge imprinting in memory about 
chemical content of gastric juice, digestion of proteins with proteolytic enzymes 
of digestive juices, mechanisms of their activation; studying of amino acids 
reactions by amino group.
THEORETICAL QUESTIONS:
1. Digestion and absoiption of amino acids.
2. Dynamic state of proteins in the body. Nitrogen balance. Biological signific­
ance of nutritional proteins and protein norms in nutrition.
3. Regulation of digestion by hormones of the gastrointestinal tract.
4. Types of gastric juice acidity.
5. Transamination of amino acids: sequence of reactions, significance. Characte­
ristics of transaminases.
6. Indirect deamination of amino acids.
7. Oxidative deamination of amino acids: chemical mechanism, characteristics 
of enzymes.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
154-161.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 231-237.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 248-261.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 399-406.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 20
Date
THEME: METABOLISM AND FUNCTIONS OF AMINO ACIDS. 
DECARBOXYLATION OF AMINO ACIDS. DETOXICATION OF
AMMONIA
The purpose of the lesson: studying of amino acids reactions by car­
boxylic group, ammonia detoxication in organism; mastering of the quantitative 
methods of determination of urea.
THEORETICAL QUESTIONS:
1. Decarboxylation of amino acids.
1.1. Characteristics of the enzymes, their activity. Chemism of the process. 
Role of amines.
1.2. Decarboxylation of tyrosine, tryptophan, 5-hydrohytryptophan, histidine. 
Chemism. Pole of formed amines.
1.3. Decarboxylation of glutamic acid and aspartic acid, cysteine, phenylala­
nine, ornithine, lysine. Chemism. Pole of amines formed.
1.4. Detoxification of biogenic amines. Characteristics of MAO and DAO. 
Chemism.
2. Detoxication of ammonia in organism.
2.1. Sources of ammonia in organism.
2.2. Local detoxication of ammonia, mechanisms. Role of glutamine. Reduc­
tive animation of a-ketoglutarate, its significance. Glucose-alanine cycle.
2.3. General detoxication of ammonia, localization. Urea synthesis. Chemism 
of the process.
2.4. Hyperammonemias.
2.5. Ammonium salts synthesis in the kidney, significance of the process.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 138-139, p. 133.
2. Task from «Clinical Biochemistry»№№ 27, 30, 35, p. 108-110.
LABORATORY WORK:
Quantitative determination of urea by enzymatic method in the se­
rum.
Principle: Urea in the blood is converted to ammonia and C 0 2 by the 
action of urease enzyme. Ammonia reacts with chromogen in the presence of 
sodium hypochlorite to form coloured complex. Concentration of coloured
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product is measured on photoelectric colorimeter. Concentration of blood urea is 
directly proportional to the colour intensity.
Diagnostic significance:
A. Physiologic Basis: Urea, an end product of protein metabolism, is 
excreted by the kidney. The urea concentration in the glomerular filtrate is the 
same as in the plasma. Tubular reabsorption of urea varies inversely with rate of 
urine flow. Thus, urea is a less useful measure of glomerular filtration than is 
creatinine, which is not reabsorbed. Blood urea nitrogen varies directly with pro­
tein intake and inversely with the rate of excretion of urea.
B. Interpretation:
1. Elevated in
• Extra-renal conditions are due to increased nitrogen metabolism associated 
with diminished renal blood flow or impaired renal function - dehydration 
(from any cause) and upper gastrointestinal bleeding (combination of in­
creased protein absorption from digestion of blood plus decreased renal 
blood flow), diabetic coma, thyrotoxicosis.
• Pre-renal conditions are due to decreased renal blood flow - shock, adrenal 
insufficiency, diabetes mellitus, dehydration, cardiac failure, etc.
• Renal conditions are due to renal insufficiency - nephritis, acute and chronic; 
acute renal failure (tubular necrosis).
• Post-renal conditions are due to enlargement of prostate, urinary tract ob­
struction, due to tumors, stones, etc.
2. Decreased in hepatic failure, nephrosis not complicated by renal in­
sufficiency, cachexia, pregnancy, malnutrition and starvation.
Urea, Serum: Normal -  2,5-8,3 mmol/1 (8-25 mg/dL),
Urea, Urine: Normal -  333,0-587,7 mmol/L (21-53 mg/dL).
Reagents: 1. Reagent 1 (enzymatic reagent), Reagent 2 (chromogen), 
Reagent 3 (sodium hypochlorite); 2. Urea standard solution; 3. Blood serum.
Practical procedure:
Take 3 test tubes and label as test (T), standard (S) and blank (B) as 
shown in the table below:
Pipette Test-tube 1 
Test
Test-tube 2  
Standard
Test-tube 3 
Blank
Blood serum 0.01ml - -
Urea standard solution - 0.01ml -
Reagent 1 0.25ml 0.25ml 0.25ml
incubation a t 37°C for 10 min
Reagent 2 (chromogen) 0.5ml 0.5ml 0.5ml
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Reagent 3 (sodium hypochlorite) 0.5ml 0.5ml | 0.5ml
incubation at 37°C for 5 min
Add 0.01ml of researched serum and 0.25ml of Reagent 1 in a test-tube 
1, 0.01ml of urea standard solution and 0.25ml of Reagent 1 in a test-tube 2 and
0.25ml of Reagent 1 in a test-tube 3. Mix thoroughly the contents of the test- 
tubes and incubate at 37°C for 10 minutes
After incubation add 0.5 ml of Reagent 2 and Reagent 3 in all test-tubes 
(test- tube 1, test-tube 2, and test-tube 3) sequentially, incubate at 37°C for 5 mi­
nutes. The coloured solutions (test-tubes 1 or 2) are placed in cuvettes (the layer 
thickness=lcm) and analyzed on a photoelectric colorimeter against blank (test- 
tube 3) at 590 nm wavelength. Determine the optical densities of standard and 
test.
Calculation
Determine the concentration of blood urea using the formula:
Ct = (Et * Cs) / Es,
Where Ct - concentration of the urea in test-tube 1 (Test), Et - optical 
density of test in test-tube 1 (Test), Cs - concentration of the urea standard solu­
tion in test-tube 2 (Standard), Es - optical density of standard in test-tube 2 (Stan­
dard).
Write down the results and make a conclusion:____________________
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p.
162-169.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 237-249.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 339-247.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 395-398,407-412.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 21
Date
THEME: METABOLISM AND FUNCTIONS OF 
INDIVIDUAL AMINO ACIDS
The purpose of the lesson: knowledge imprinting in memory about 
conversions of amino acids in the tissues; studying of the some amino acids me­
tabolism; mastering of the methods of phenyl pyruvate qualitative determination 
and diagnostics of phenylketonuria by thin layer chromatography of blood amino 
acids.
THEORETICAL QUESTIONS:
1. Phenylalanine and tyrosine metabolism.
1.1. Use of tyrosine for synthesis of catecholamines, thyroid hormones, me­
lanin.
1.2. Tyrosine metabolism into fumarate and acetoacetate.
1.3. Hereditary defects in phenylalanine and tyrosine metabolism: phenylke­
tonuria, alkaptonuria, albinism, tyrosinosis, Parkinson's disease.
2. Methylation and transmethylation reactions.
2.1. S-adenosylmethionine -  universal donor of methyl radicals for sub­
strates, itsformation.
2.2. Methylation reactions: synthesis of creatinine, epinephrine, phosphati­
dylcholine.
2.3. Role of tetrahydrofolic acid in methylation.
QUESTIONS AND EXERCISES:
MSQ from «Clinical Biochemistry» №№ 140,145, p. 133-134. 
LABORATORY WORK:
1. Quantitative reaction on phenylpyruvate (Feling’s sample).
Principle: Phenylpyruvate reacts with iron ions to form the complex of blue- 
green color.
Diagnostic significance: Phenylketonuria is inherited as an autosomal 
recessive trait (both parents must pass on the defective gene for the child to be 
affected). The genetically-determined abnormality in phenylketonuria is a miss­
ing enzyme called phenylalanine hydroxylase. In PKU, phenylalanine cannot be 
used in a normal fashion because of the missing enzyme. Subsequently, high 
levels of phenylalanine, and 2 closely-related phenylalanine derivatives, build
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up in the body. These compounds are toxic to the central nervous system and 
cause brain damage. Damage to the brain causes marked mental retardation by 
the end of the first year of life if  the offending proteins are not scrupulously 
avoided. Older children may develop movement disorders (athetosis), rocking, 
and hyperactivity. PKU is a treatable disease that can be easily detected by a 
simple blood test. Most states require a screening test for all newborns, generally 
done with a heelstick shortly after birth. Blood is routinely drawn from newborn 
infants for testing. Blood is obtained by "heel stick" and collected on a special 
blotter paper.
Because phenylalanine is involved indirectly in the production of mela­
nin, children with phenylketonuria often have lighter complexions than their un­
affected siblings. There is a characteristic "mousy" odor that results from the ac­
cumulation of phenylacetic acid. This odor may be detected on the breath, skin, 
and urine if the condition has not been treated immediately from birth or if foods 
containing phenylalanine are consumed.
Reagents: 1. Urine 1 and 2; 2. Iron chloride solution; 3. Filter papers.
Practical procedure:
Put several urine drops on 2 filter papers; add 8-10 drops of iron chloride solu­
tion.
Write down the results and make a conclusion:
2. Diagnostics of phenylketonuria by thin layer chromatography of 
blood amino acids.
Principle: At phenylketonuria the content of phenylalanine in blood ex­
ceeds normal in 30 and more times (norm of 85-115 p.mol/1). It is possible to 
detect such quantity of phenylalanine by thin layer chromatography of amino ac­
ids on plates "Fixion 50x8".
All amino acids should be absorbed in a start position by their exchange 
with Na+ when sample is applied on a plate. Hence, all amino acids in initial test 
should be in form of cations, that is reached by finishing of a put solution till pH 
less than 2,2. Deduction of amino acids by pitch depends on degree of dissocia­
tion of the amine- and carboxylic groups of amino acid (i.e. pH), number of 
these groups in a molecule, ability to hydrophobic interactions with pitch and 
some other conditions. Aromatic and basic amino acids (Arg, His, Lys, Phe, 
Leu, Тут) are strongly attached to cationite. It is applied passing through a pitch 
layer nitrate buffer pH 5.25 with concentration Na+ 0,35M for their division. In 
these conditions all other amino acids (acid and neutral) get high mobility and 
pass with solvent front. For revealing of separate amino acids a plate is sprayed
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lightly with ninhydrin. There are violet spots of the amino acids which are set­
tling down on length of the plate in specified above sequence on degree of ami­
no acids mobility increase. The semiquantitative estimation of the amino acid 
maintenance in the mix is reached by comparison of spot size from the analyzed 
sample with the spot of corresponding standard amino acid.
Test preparation consists in separation of blood serum from proteins by sulfosa- 
licylic acid sedimentation: add 1 ml o f 3% sulfosalicylic acid to 1 ml of sick and 
healthy child serum. Shake mix by spare capillary. Separate protein precipitate 
by centrifugation at 3000 revolutions per minute for 10 minutes.
Reagents: 1. Sulfosalicylic acid solution, 30 g/L; 2. Phenylalanine stan­
dard solution, 4 pmol/ml; 3. Citrate buffer, pH 5,28; 4. Ninhydrin solution; 5. 
Blood serum.
Practical procedure:
Place samples of deproteinized serum of the sick and healthy child in 
starting points (7) on the plate "Fixion 50x8" by 15-20 contacts on to each point 
(2) with a capillary tube. Place phenylalanine working solution in the others 5 
points by 1, 3, 5, 7, and 9 contacts that corresponds 0,5, 1,5, 2,5, 3,5 and 4,5 pL 
(0,5 pL of solution contains -  2,10'3 (!) gmol of phenylalanine).
Then spend chromatographic separation and colouring of spots. Amino acids 
present in the mixture should appear as purple/blue spots. Compare phenylala­
nine spot of the serum with phenylalanine spot o f the standard during semiquan­
titative estimation. Thus it is necessary to remember, that concentration of ami­
no acids in blood (Съ) and standard solution of amino acid (Cst) are inversely 
proportional to the put volumes (or quantity of contacts) at the equal intensity of 
colouring and size of compared spots. Besides, blood has been twice diluted dur­
ing sedimentation of proteins. Therefore:
Cst Vb
Cb = ------------  2 1000
Vst
Usually result is expressed by two limiting values, corresponding to the 
phenylalanine content in two spots of standard scale between which it is possible 
to arrange corresponding phenylalanine blood spot by intensity of colouring.
Write down the results and make a conclusion:____________________ _
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M AIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
170-174.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 249-264.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 262-270.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 399-406.
Lesson is passed
(The signature of the teacher)
LESSON 22
Date
COLLOQUIM: PROTEIN AND LIPID METABOLISM
The purpose of the lesson: knowledge imprinting in memory about the
proteins and lipids metabolism, their connection with energy.
MAIN THEORETICAL QUESTIONS:
1. Digestion of proteins. Absorption of amino acids. Dynamic state of proteins 
in the body. Nitrogen balance. Biological value of nutritional proteins and 
protein norms in nutrition. Regulation of digestion by hormones of the ga­
strointestinal tract. Types of acidity of gastric juice.
2. Transamination of amino acids: sequence of reactions, significance. Charac­
teristics of transaminases. Indirect deamination of amino acids.
3. Oxidative deamination of amino acids: chemical mechanism, characteristics 
of enzymes. Reductive amination of a-ketoglutarate, its significance.
4. Decarboxylation of amino acids. Production of biogenic amines, their role in 
regulation of metabolism and functions, detoxication.
5. General detoxication of ammonia: synthesis of urea and ammonium salts, 
significance of the processes.
6. Transmethylation. Methionine and S-adenosylmethionine (participation in 
the synthesis of creatinine, epinephrine, phosphatidylcholine and methyla- 
tion of xenobiotics). Role of tetrahydrofolic acid in methylation.
7. Phenylalanine and tyrosine metabolism. Use of tyrosine for synthesis of ca­
techolamines, thyroid hormones, melanins. Tyrosine metabolism into fuma- 
rate and acetoacetate. Hereditary defects in phenylalanine and tyrosine me­
tabolism.
8. Major human tissue lipids. Functions of lipids. Deposition and mobilization 
of fats in adipose tissue. Regulation. Transport and uptake of fatty acids. 
Chemical mechanism of glycerol oxidation.
9. Eicosanoids and their role in regulation of metabolism and physiological 
functions.
10. Nutritional fats: digestion, absorption of the products of digestion. Role of 
bile acids. Lipid transport in the body.
11. Transport blood lipoproteins: characteristics, synthesis, physiological role. 
Lipoprotein lipase. Types of hyperlipoproteinemias. Biochemistry of athe­
rosclerosis.
12. Activation and oxidation of fatty acids: sequence of reactions, physiological 
significance. Biosynthesis and use of ketone bodies.
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13. Biosynthesis of fatty acids: synthesis and role of malonyl-CoA, characteris­
tics of palmitate synthase complex, regulation. Production of long-chain fat­
ty acids and unsaturated fatty acids.
14. Biosynthesis of triacylglycerols, glycerophospholipids.
15. Metabolism and functions of cholesterol, direct and reverse transport. Bio­
synthesis of cholesterol: sequence of reactions, regulation.
16. Major pathological processes associated with disorders of acetyl-CoA meta­
bolism (fasting, obesity, atherosclerosis, cholelithiasis, diabetes).
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» M s  102-137, 138-140, 145, p.
127-132, 133-134.
2. Task from «Clinical Biochemistry» №№ 11, 13,24, 27, 30, 35, p. 104-
107, 108-110.
MAIN LITERATURE:
1.
2.
Lecture,
Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p.
127-174.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 23
Date
THEME: STRUCTURE OF NUCLEIC ACIDS. METABOLISM OF 
NUCLEOTIDES
The purpose of the lesson: studying of structure and nitrogenous bases 
biosynthesis, their degradation.
THEORETICAL QUESTIONS:
1. Nucleoproteids, structure, role in the cell. Histones, characteristics. Nucleic 
acids are prosthetic groups of nucleoproteids, their structural monomers.
2. Structural components of the mononucleoproteids.
3. Nucleosides, nucleotides.
4. DNA. Primary and secondary structures of DNA. Localization in the cell.
5. Tertiary structure of DNA. Structural organization of DNA in chromatin and 
chromosomes.
6. Physico-chemical properties of DNA.
7. RNA. Types of RNA, structure, localization in the cell, functions. Primary 
and secondary structures of RNA.
8. Purine and pyrimidine nucleotides biosynthesis.
9. Purine and pyrimidine nucleotides degradation.
10. Nucleotide metabolism disorders (gout, xanthinuria, orotaciduria).
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 23-28, 31, p. 116-117.
2. Task from «Clinical Biochemistry» №№ 16, p. 106.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p . , 
175-180,185,191-194.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 47-55.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 285-311.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 173-177, 193-194, 
228-240.
Lesson is passed______________________
(The signature o f the teacher)
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LESSON 24
Date
THEME: REPLICATION. TRANSCRIPTION. TRANSLATION
The purpose of the lesson: studying of the processes of nucleic acids 
biosynthesis, protein biosynthesis; knowledge imprinting in memory about nuc­
leotide metabolism, structure and functions of nucleic acids, their role in protein 
biosynthesis.
THEORETICAL QUESTIONS:
1. DNA biosynthesis (replication): mechanism and biological significance.
2. Replication and phases of the cellular cycle.
3. DNA damages and replication errors repair.
4. RNA biosynthesis (transcription).
5. Genetic code.
6. Biosynthesis o f proteins (translation). Major components of protein- 
synthesizing system.
7. Amino acid activation. Amino acyl-t-RNA synthesis. Substrate nature of 
amino acyl-t-RNA synthases. Adaptive function of t-RNA, role of m-PNA.
8. Initiation stage of translation. Structure of ribosomes and polyribosomes. 
Ribosome functioning.
9. Elongation stage of translation.
10. Termination stage of translation.
11. Regulation of gene activity. Induction and repression of protein synthesis in 
the human body. Role of hormones in the gene activity regulation.
12. Medicinal preparations as matrix synthesis inhibitors in prokaryotes and eu­
karyotes.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 29, 30, 32, p. 166-117.
2. Task from «Clinical Biochemistry» №№ 17,19, p. 106.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
180-184,186-191,195-202.
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Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 55-85.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 312- 
368.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 195-227, 241-256.
Lesson is passed
(The signature o f  the teacher)
LESSON 25
Date
THEME: REGULATION OF METABOLISM. HORMONES. 
PITUITARY AND HYPOTHALAMIC HORMONES. HORMONES OF
THE GONADS
The purpose of the lesson: studying of the chemical nature of hormones 
and mechanisms of metabolism hormonal regulation; studying of the hypotha­
lamic and pituitary hormones, hormones of the gonads.
THEORETICAL QUESTIONS:
1. Hierarchy of regulatory systems.
2. Definition of hormones. Role of hormones in the system o f regulation of me­
tabolism and organ functions.
3. Classification of hormones according to their chemical structure and me­
chanism of action. Major mechanisms of metabolic regulation.
4. Central regulation of endocrine system: hormones of hypothalamus and trop­
ic hormones of the pituitary.
5. Male hormones: structure, effect on metabolism. Anabolics of steroid struc­
ture.
6. Female hormones: structure, role in the sex cycle, effect on metabolism.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 148, p. 135.
2. Task from «Clinical Biochemistry» №№ 31, p. 109.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
203-237.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 275-294.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 444-458.
3. D. Hames and N. M. Hooper. Biochemistry, 2005, p. 156-166.
Lesson is passed______________________
(The signature o f the teacher)
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LESSON 26
D ate
THEME: HORMONES OF THE ADRENAL CORTEX. HORMONES OF 
THE ADRENAL MEDULLA. HORMONES OF THE PANCREAS
The purpose of the lesson: studying of the hormones of the adrenal cor­
tex, adrenal medulla and pancreas.
THEORETICAL QUESTIONS:
1. Insulin: structure, synthesis, biological action.
2. Characteristics of metabolic disorders in diabetes mellitus. Biochemical me­
chanisms of development of complications in diabetes mellitus.
3. Epinephrine and norepinephrine: structure, synthesis, effect on metabolism.
4. Glucocorticosteroids. Their structure, effect on metabolism. Manifestation of 
hyper- and hypofunction.
5. Mineralocorticosteroids. Their structure, effect on metabolism. Manifesta­
tion of hyper- and hypofunction. Renin-agiotensin system. Biochemical me­
chanisms of renal hypertension development.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 149, p. 135.
2. Task from «Clinical Biochemistry» №№ 6, 20,23, 28, 33, p. 104,107-
109.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
238-268.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 275-294.
Lesson is passed______________________
(The signature of the teacher)
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LESSON 27
Date
THEME: THYROID HORMONES. HORMONES THAT REGULATE 
CALCIUM METABOLISM
The purpose of the lesson: studying of the thyroid hormones; studying
of the calcium and phosphates metabolism; studying of the hormones that regu­
late calcium metabolism; knowledge imprinting in memory about theme "Regu­
lation of metabolism" (control test).
THEORETICAL QUESTIONS:
1. Characteristics of mineral metabolism: calcium, phosphates, zink, magne­
sium. Functions, metabolism regulation, disorders. Special features of mineral 
metabolism in connection with Chernobyl accident.
2. Metabolism of calcium and phosphates: role o f parathyroid hormone, calcito­
nin, vitamin D3.
3. Iodothyronines: structure, synthesis, metabolism, their effect on metabolism. 
Hypo- and hyperthyroidism. Features of thyroid gland functioning in connec­
tion with Chernobyl accident.
QUESTIONS AND EXERCISES:
MSQ from «Clinical Biochemistry» №№ 146,147,150, p. 134-135.
CONTROL TEST: «HORMONS»
Main theoretical questions:
1. Hierarchy of regulatory systems. Role of hormones in the system of regula­
tion of metabolism and organ functions. Classification of hormones accord­
ing to their chemical structure and mechanism of action. Major mechanisms 
of metabolic regulation.
2. Central regulation of endocrine system: hormones of hypothalamus and trop­
ic hormones of the pituitary
3. Insulin: structure, synthesis, biological action. Characteristics of metabolic 
disorders in diabetes mellitus. Biochemical mechanisms of development of 
complications in diabetes mellitus.
4. Regulation of water-salt metabolism. Structure, mechanism of action of va­
sopressin and aldosterone. Renin-agiotensin system. Biochemical mechan­
isms of renal hypertension development.
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5. Epinephrine and norepinephrine: structure, synthesis, effect on metabolism.
6. Iodothyronines: structure, synthesis, metabolism, their effect on metabolism. 
Hypo- and hyperthyroidism. Features of thyroid gland functioning in con­
nection with Chernobyl accident.
7. Hormones of adrenal cortex: gluco- and mineralocorticosteroids. Their struc­
ture, effect on metabolism. Manifestation of hyper- and hypofimction.
8. Metabolism of calcium and phosphates: role of parathyroid hormone, calci­
tonin, vitamin D3.
9. Male hormones: structure, effect on metabolism. Anabolics of steroid struc­
ture. Female hormones: structure, role in the sex cycle, effect on metabol­
ism.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
269-284.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 275-294.
Lesson is passed___________________
(The signature of the teacher)
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LESSON 28
Date
THEME: INTRODUCTION IN VITAMINOLOGY. LIPID-SOLUBLE
VITAMINS
The purpose of the lesson: knowledge imprinting in memory about
structure and biological role of fat-soluble vitamins.
THEORETICAL QUESTIONS:
1. Vitamins, general characteristics, classification, functions. Pathologic states 
due to vitamin metabolism disorders. Specificity of fat-soluble vitamins.
2. Vitamin A: structure, biological role, sources, recommended dietary allow­
ance. Hypo-, a- and hypervitaminosis.
3. Vitamin D. Structure, biological role, natural sources, recommended dietary 
allowance. Hypo-, a- and hypervitaminosis.
4. Vitamin K: structure, biological role, natural sources, recommended dietary 
allowance, manifestations of deficiency. Water-soluble drugs.
5. Vitamin E: its structure, biological role, natural sources, recommended dieta­
ry allowance. Manifestations of deficiency.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
285, 300-308.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 109-110.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 467-481.
Lesson is passed____________________
(The signature of the teacher)
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LESSON 29
Date
THEME: WATER-SOLUBLE VITAMINS. 
VITAMINS С, P, Вь B2, B6, PP
The purpose of the lesson: knowledge imprinting in memory about
structure and biological role of water-soluble vitamins.
THEORETICAL QUESTIONS:
1. Vitamin C: structure, biological role, natural sources, recommended dietary 
allowance. Hypo- and avitaminosesis.
2. Vitamin P: structure, biological role, natural sources, recommended dietary 
allowance. Hypo- and avitaminosesis.
3. Vitamin Bt: structure, biological role, natural sources, recommended dietary 
allowance. Avitaminosis.
4. Vitamin B2: its structure (co-enzyme forms), biological role, natural sources, 
recommended dietary allowance.
5. Vitamin B6: its structure (co-enzyme forms), biological role, natural sources, 
recommended dietary allowance.
6 . Vitamin PP: its structure (co-enzyme forms), biological role, natural sources, 
recommended dietary allowance.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 8 , 158-166, p. 113,136-137.
2. Task from «Clinical Biochemistry» №№ 25, p. 108.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
286-290, 291-293,298-299.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 103-109.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 467-481.
Lesson is passed____________________
(The signature of the teacher)
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LESSON 30
Date
THEME: WATER-SOLUBLE VITAMINS.
VITAMINS Bn , FOLIC АСШ, PANTOTHENIC ACID, BIOTIN
The purpose of the lesson knowledge imprinting in memory about 
structure and biological role of water-soluble vitamins, (control test); familiariz­
ing with vitamin C quantitative determination in blood.
THEORETICAL QUESTIONS:
1. Biotin. Its structure, biological role (examples of carboxylation reaction), 
sources.
2. Pantothenic acid. Its structure, biological role (examples of carboxylation 
reaction), sources.
3. Folic acid. Structure, folate co-enzymes, recommended dietary allowance. 
Sulfanilamides as antimetabolites.
4. Vitamin B i2. Structure, biological role, natural sources, recommended dietary 
allowance. Pernicious anemia.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 143, 144, 151-157, p. 134-
136.
2. Task from «Clinical Biochemistry» №№ 7, 32, p. 104,109.
LABORATORY WORK:
Quantitative determination of vitamin C in blood.
Clinical importance: In febrile conditions, infections and stress, vitamin 
C is lost heavily from the body. Hence, adequate quantities of this vitamin 
should be taken in such conditions. The usefulness of this vitamin in many pa­
thological conditions like atherosclerosis, deep vein thrombosis, diabetes melli- 
tus, cancer, skin diseases, frost-bite and in common cold and maintenance of 
youthfulness invites one to call it the 'versatile' vitamin. The determination of 
the plasma levels of ascorbic acid is an indicative of the ascorbic acid status of 
an individual.
Reagents: 1. 2,6-dichlorophenol indophenol solution, 0,0001 N; 2. So­
dium chloride solution, 9 g/L; 3. Sulfosalicylic acid solution, 200 g/L; 4. Blood.
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Practical procedure:
Place 1 ml of blood and 3 ml of physiological sodium chloride solution 
in the rotary test tube. Separate red blood cells from plasma during 15 minutes 
by centrifugation (3000 revolutions per minute). Separate plasma mix with so­
dium chloride solution from precipitate. Place it in another rotary test tube and 
add 2 ml of sulfosalicylic acid solution. Separate protein by centrifugation (15 
minutes). Pour out supernatant in a glass and titrate with 2,6-dichlorophenol in- 
dophenol, which is reduced by vitamin, till pink colouring is produced.
Calculate using the formula: 0,05 -1000 = X pmol/l,
Where 0,005 - quantity of the ascorbic acid in pmol, corresponding 1 ml 0,001N 
of 2,6 dichlorophenol indophenol. Make conclusion.
CONTROL TEST: «VITAMINS»
Main theoretical questions:
1. Vitamins, general characteristics, classification, functions. Pathologic states 
due to vitamin metabolism disorders. Specificity of fat-soluble vitamins.
2. Vitamin A: structure, biological role, sources, recommended dietary allow­
ance. Hypo-, a- and hypervitaminosis.
3. Vitamin D. Structure, biological role, natural sources, recommended dietary 
allowance. Hypo-, a- and hypervitaminosis.
4. Vitamin K: structure, biological role, natural sources, recommended dietary 
allowance, manifestations of deficiency. Water-soluble drugs.
5. Vitamin E: its structure, biological role, natural sources, recommended die­
tary allowance. Manifestations of deficiency.
6 . Vitamins C and P, their structure, biological role, natural sources, recom­
mended dietary allowance. Hypo- and avitaminosesis.
7. Vitamin Bp structure, biological role, natural sources, recommended dietary 
allowance. Avitaminosis.
8 . Vitamin B2 and PP: their structure (co-enzyme forms), biological role, natu­
ral sources, recommended dietary allowance.
9. Biotin. Pantothenic acid. Its structure, biological role (examples of carbox- 
ylation reaction), sources.
10. Folic acid. Structure, folate co-enzymes, recommended dietary allowance. 
Sulfanilamides as antimetabolites.
11. Vitamin B !2. Structure, biological role, natural sources, recommended dieta­
ry allowance. Pernicious anemia.
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M AIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
290-291,294-298.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 103-109,249-253.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 467-481.
Lesson is passed___________________
(The signature o f the teacher)
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LESSON 31
Date
THEME: BIOCHEMISTRY OF BLOOD. BLOOD PROTEINS. 
HEMOGLOBIN. METABOLISM OF IRON AND COPPER
The purpose of the lesson: knowledge imprinting in memory about 
chemical composition and biological role of blood, hemoglobin role, about me­
chanisms of oxygen and carbon dioxide transport; studying of the hemoglobin 
synthesis, kinds of its heterogeneity. Studying of the iron and copper metabol­
ism; familiarizing with benzidine test on blood and quantitative method of he­
moglobin determination according to Drabkin.
THEORETICAL QUESTIONS:
1. General characteristics and functions of blood.
2. Blood plasma proteins and enzymes.
2.1 .Albumins, their functions. Hyper- and hypoalbuminemias.
2.2. Globulins, their functions. Hyper- and hypoglobulinemias.
3. Erythrocyte proteins.
3.1 .Hemoglobin and its derivatives. Methemoglobinemia.
3.2. Types ofhemoglobin. Hemoglobinopathy.
3.3. Synthesis of heme and hemoglobin, its regulation.
3.4. Erythrocytes metabolism: role of glycolysis and pentose phosphate path­
way.
4. Iron metabolism: transport, deposition, daily requirements.
5. Copper metabolism: transport, deposition, daily requirements.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 141, p. 133.
2. Task from «Clinical Biochemistry» №№ 36, 40, p. 110-111.
LABORATORY WORK:
1. Benzidine test.
Principle: Blood can be detected by preparing derivatives of hemoglo­
bin like hemochromogen and hemin crystals. Hemoglobin decomposes hydro­
gen peroxide to liberate nascent oxygen (O') which oxidizes benzidine to deeply 
greenish-blue coloured complex. This is due to the catalytic effect of hemoglo­
bin-haptoglobin complex which has peroxidase activity.
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Diagnostic significance:
Reaction is very sensitive and detects the presence of blood. This reaction 
is taken as a principle detection of the latent blood in faeces, and also for control 
of presterilization clearing of toolkit and ware in clinical practice.
Reagents: 1. Defibrinated blood diluted by water; 2. Benzidine solution, 
50 g/L; 3. Hydrogen peroxide solution, 30g/L.
Practical procedure:
Place 5 drops of blood and 5 drops of benzidine in the test-tube 1. Then 
add 5 drops of hydrogen peroxide. In the test-tube 2 place 5 drops of distilled 
water, 5 drops of benzidine and 5 drops of hydrogen peroxide. Compare re­
ceived results.
Write down the results and make a conclusion:____________________________
2. Quantitative determination of hemoglobin by Drabkin's method.
Principle: Hemoglobin reacts with potassium hexacyanoferrate(III) to 
form methemoglobin in appropriate medium. Methemoglobin in blood is con­
verted to cyanmethemoglobin. The absorbance at 530-550 nm is proportional to 
the hemoglobin concentration in blood.
Diagnostic significance: Quantitative determination of hemoglobin is 
used to recognize anemia. Anemia is typically defined as hemoglobin <120 g/1. 
Increased levels of hemoglobin are associated with clotting, erythremia.
Hemoglobin: Normal: m-130-170 g/L (2,09-2,79 mmol/L), 
f-120-150 g/L (1,86-2,48 mmol/L).
Reagents: 1. Drabkin's reagent (potassium hexacyanoferrate (Ш), 
Na2C 0 3, C 02, KCN);
2. Blood.
Note: for studying purposes Drabkin s reagent is prepared without KCN!
Practical procedure:
Mix 0,02ml of blood and 5ml of Drabkin's reagent in the test-tube. The 
coloured solution in 10  minutes placed in cuvettes (the layer thickness=10mm) 
and analyzed on a photoelectric colorimeter supplied with a green light filter 
(X=630-690nm).
Multiply received extinction on 361 which is established by practical 
consideration.
The received result corresponds to concentration of hemoglobin in g/1. 
The multiplication of received result on 0.0153 is concentration of hemoglobin 
inmmol/l.
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Write down the results and make a conclusion:
MAIN LITERATURE:
1. Lecture,
2. Clinical biochemistry. Materials for the state examination in biochemistry. 
Konevalova N.Yu., Buyanova S.V., 2005 p. 11-18.
Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 30-31, 260-262.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 566-582, 
593-608.
Lesson is passed
(The signature o f the teacher)
LESSON 32
Date
THEME: BIOCHEMISTRY OF KIDNEYS
The purpose of the lesson: Studying of the kidneys functional bioche­
mistry.
THEORETICAL QUESTIONS:
1. Functional biochemistry of kidneys, specific features of metabolism, func­
tions of kidneys.
2. Urine formation, notion of renal threshold substances.
3. Renal insufficiency, its manifestations. Renal stones.
4. Urine components, proteinuria.
MAIN LITERATURE:
1. Lecture.
Lesson is passed___________________
(The signature of the teacher)
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LESSON 33
Date
COLLOQUIM: INTEGRATION OF METABOLISM. 
REGULATION OF METABOLISM
The purpose of the lesson: knowledge imprinting in memory about me­
tabolism integration of proteins, lipids and carbohydrates; regulation of metabol­
ism.
MAIN THEORETICAL QUESTIONS:
1. Integration of amino acid, fat, carbohydrate metabolism. Manifestations of 
this integration. Major sites of integration (glucose-6 -phosphate, pyruvate, 
acetyl-CoA, CAC substrates).
2. Sources and pathways of blood glucose uptake. Regulation of blood glucose 
level by insulin, glucagon, epinephrine and glucocorticoids.
3. Hierarchy of regulatory systems. Role of hormones in the system of regula­
tion of metabolism and organ functions. Classification of hormones accord­
ing to their chemical structure and mechanism of action. Major mechanisms 
of metabolic regulation.
4. Central regulation of endocrine system: hormones of hypothalamus and trop­
ic hormones of the pituitary.
5. Insulin: structure, synthesis, biological action. Characteristics of metabolic 
disorders in diabetes mellitus. Biochemical mechanisms of development of 
complications in diabetes mellitus.
6 . Regulation of water-salt metabolism. Structure, mechanism of action of va­
sopressin and aldosterone. Renin-agiotensin system. Biochemical mechan­
isms of renal hypertension development.
7. Epinephrine and norepinephrine: structure, synthesis, effect on metabolism.
8 . Iodothyronines: structure, synthesis, metabolism, their effect on metabolism. 
Hypo- and hyperthyroidism. Features of thyroid gland functioning in con­
nection with Chernobyl accident.
9. Hormones of adrenal cortex: gluco- and mineralocorticosteroids. Their struc­
ture, effect on metabolism. Manifestation of hyper- and hypofunction.
10. Metabolism of calcium and phosphates: role of parathyroid hormone, calci­
tonin, vitamin D3.
11. Male hormones: structure, effect on metabolism. Anabolics of steroid struc­
ture. Female hormones: structure, role in the sex cycle, effect on metabol­
ism.
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12. Major mechanisms of metabolic regulation: changes in enzyme activity, 
amount of enzymes in the cell, membrane permeability. Regulation of car­
bohydrate, fat and amino acid metabolism by glucagon, cortisol and insulin.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 146-150, p. 134-135.
2. Task from «Clinical Biochemistry» №№ 6 , 20,23, 28, 31, 33, p. 104, 
107-109.
MAIN LITERATURE:
1. Lecture,
2. Biochemistry. Lecture course. Konevalova N.Yu., Buyanova S.V., 2005, p. 
203-284.
3. Clinical biochemistry. Materials for the state examination in biochemistry. 
Konevalova N.Yu., Buyanova S.V., 2005 p. 4-10.
Lesson is passed___________________
(The signature o f the teacher)
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LESSON 34
Date
THEME: BIOCHEMISTRY OF LIVER CARCINOGENESIS
The purpose of the lesson: studying of the liver role in various kinds of 
metabolism and detoxication of substances; understanding of «carcinogenesis» 
concept, role of oncogenes and growth factors.
THEORETICAL QUESTIONS:
1. Liver, its functions. Specific features of metabolism in the liver. Role of the 
liver in metabolism of carbohydrates, lipids, proteins, amino acids, vitamins.
2. Catabolism of heme. Unconjugated and conjugated bilirubin. Disorders of bi­
lirubin metabolism.
3. Types of jaundice (hemolytic, parenchimal, obstructive).
4. Biochemical mechanisms of pathogenesis of hepatic insufficiency, serous- 
biochemical hepatic syndromes.
5. Major mechanisms of detoxication of substances in the liver: microsomal 
oxidation, reactions of conjugation. Examples of detoxication of foreign sub­
stances (phenol), protein putrifaction products (cresol, indole).
6 . Significance of drug metabolism, factors influencing drug metabolism.
7. Role of physical, chemical and biological factors in carcinogenesis. Laborato­
ry diagnosis of cancer. Key role of DNA in carcinogenesis. Risk factors re­
sponsible for human carcinogenesis.
8 . Role of oncogenes in tumour pathogenesis. Types of oncogenes. Mechanisms 
of protooncogene activation.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 142, p. 133.
2. Task from «Clinical Biochemistry» №№ 4, 37, 39, p. 103,110-111.
MAIN LITERATURE:
1. Lecture,
2. Clinical biochemistry. Materials for the state examination in biochemistry. 
KonevalovaN.Yu., Buyanova S.V., 2005 p. 19-45.
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Literature for essay:
1. D.B. Marks «Biochemistry», 1994, p. 9, 84-85, 260-261.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 271-284, 
609-615.
Lesson is passed___________________
(The signature of the teacher)
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LESSON 35
THEME: THE INTERMEDIATE CONTROL OF PRACTICAL SKILLS
The purpose of the lesson: knowledge imprinting in memory received 
during studying of protein, carbohydrate and lipid metabolism research methods: 
the clinical importance of indexes determination, principle of methods, clinical 
interpretation of the received data in norm and at the pathology.
THE LIST OF THE PRACTICAL SKILLS:
1. Quantitative determination of total protein by the biuret method in the serum.
2. Quantitative determination of albumin by the bromocresol green in the serum.
3. Quantitative determination of glucose by enzymatic method in the serum.
4. Qualitative determination of sugar in urine (reaction of Nilander).
5. Quantitative determination of urea by enzymatic method in the serum.
6 . Quantitative determination of total cholesterol by enzymatic method in the se­
rum.
7. Quantitative determination of triacylglycerols by enzymatic method in the serum.
8 . Qualitative determination of ketone bodies in urine.
9. Benzidine test.
10. Qualitative determination of protein in urine (Geller s test).
11 .Quantitative reaction on phenylpyruvate (Feling's sample).
12. Calculation of lipid atherogenity (atherogenicity) index according to determina­
tion of total cholesterol, HDL and triacylglycerol concentrations.
13. Glucose, ketone bodies, proteins determination in urine with method of "dry" 
chemistry by Boehringer Mannheim test strips.
QUESTIONS AND EXERCISES:
Practical skills from «Clinical Biochemistry» p. 66-102.
MAIN LITERATURE:
1. Clinical biochemistry. Materials for the state examination in biochemistry. 
KonevalovaN.Yu., Buyanova S.V., 2005 p. 19-45.
Lesson is passed
(The signature of the teacher)
LESSON 36
Date
THEME: MUSCLE. NERVE. CONNECTIVE TISSUE
The purpose of the lesson: studying of the chemical composition and 
metabolism features in nervous, muscular and connective tissues.
THEORETICAL QUESTIONS:
1. Biochemistry of muscle.
1.1. Sarcoplasmic and myofibrillar proteins of muscles.
1.2. Molecular structure of myofibrils.
1.3. Biochemical mechanisms of muscular contraction and relaxation.
1.4. Muscular energetics: role of creatine phosphate, camosine and anserine.
1.5. Biochemistry of connective tissue.
2. General characteristics of connective tissue.
2.1. Glycosamineglycanes and proteoglycanes, fibronectin, their structure 
and biological role.
2.2. Fibrillar protein: collagen, its characteristics and biosynthesis. Role of 
vitamin C in collagen synthesis. Changes of connective tissue during aging, col- 
lagenoses, wound healing.
2.3. Fibrillar protein: elastin, its characteristics and biosynthesis.
3. Biochemistry of nervous tissue.
3.1. General characteristics and chemical composition of nervous tissue.
3.2. Specific features of nervous tissue metabolism.
3.3. Molecular mechanisms of adrenergic and cholinergic transfer, specific 
features, disorders.
QUESTIONS AND EXERCISES:
1. MSQ from «Clinical Biochemistry» №№ 98-99, p. 127.
2. Task from «Clinical Biochemistry»
MAIN LITERATURE:
1. Lecture,
2. Clinical biochemistry. Materials for the state examination in biochemistry. 
Konevalova N. Yu., Buyanova S.V., 2005 p. 46-65.
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Literature for essay:
1. D.B. Marks «Biochemistry», 1994, 31-32, 37-38,136-139.
2. Robert K. Murray et al. Harper's Illustrated Biochemistry, 2009, p. 527-565.
3. D. Hames andN. M. Hooper. Biochemistry, 2005, p. 167-172.
Lesson is passed
(The signature of the teacher)
LESSON 37
Date
THEME: METHODS OF EXPRESS-DIAGNOSTICS
The purpose of the lesson: familiarizing with principles, methods and 
possibilities of express diagnostics; studying of the "dry chemistry" method im­
portance for express diagnostics; studying of the clinical value of aminotransfe­
rase, creatinkinase, and amylase activity determination; learning of the test strips 
using for urine research.
THEORETICAL QUESTIONS:
1. Concept express-diagnostics. Express diagnostics methods, principles, signi­
ficance and a role in clinical practice.
2. Principles of work and the device of test strips of the dry chemistry "Reflo- 
tron" analyzer.
3. Clinical significance of determination of aminotransferase, creatine kinase, 
amylase activities and cholesterol level in blood serum by analyzer "Reflo- 
tron".
LABORATORY WORK:
I) The quantitative determination of aminotransferases, creatine ki­
nase, cholesterol and amylase levels in blood serum with Reflotron.
The reflotron Plus Chemistry Analyzer is an in vitro diagnostic device 
designed for the quantitative determination of clinical chemistry parameters us­
ing reflotron Test Tabs. It works on the principle of reflectance photometry and 
ensures rapid and reliable results while being easy to use. Reflectance measure­
ment based on the color change in the test strips. The results are shown on a 
clear LC display. Reflotron Tests are reagent strips for specific testing of impor­
tant clinical chemistry parameters directly from whole blood, plasma or serum. 
The parameters measured cover the most relevant indications in primary care: 
anemia, diabetes, gout, lipid disorders, liver diseases, muscle diseases, pancrea­
titis, renal diseases and bone disorders.
Procedure of with Reflotron:
1- Switch on the device and allow getting warm 1 -2 minutes.
2- Remove a protective foil.
3- Put 32 pL of serum on a protective net.
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4- Place a test strip in a special measuring cell of the device to click, close a 
cover of a measuring cell.
5- Read results on a display in 120 seconds.
6- Open the cover, remove a test strip.
Test-strip:
Protective fo il
Holding layer
Protective net
Magnetic band 
Plasma separating layer 
Transport layer 
Zone o f reaction
1. Test for the quantitative determination of aminotransferases (As­
partate transaminase and Alanine transaminase) by Reflotron.
Diagnostic significance:
A. Physiologic Basis: Aspartate aminotransferase (AST), alanine amino­
transferase (ALT) are intracellular enzymes involved in amino acid or carbohy­
drate metabolism. They catalyze the a-amino group of amino acid transfer to a- 
keto acid to form the corresponding amino acid and a-keto acid. These en­
zymes are present in high concentrations in muscle, liver, and brain. Elevations 
of concentrations of these enzymes in the blood indicate necrosis or disease, es­
pecially o f these tissues.
B. Interpretation:
1. Elevated after myocardial infarction (especially AST); acute infec­
tious hepatitis (ALT usually elevated more than AST); cirrhosis of the liver 
(AST usually elevated more than ALT); and metastatic or primary liver neop­
lasm. Elevated in transudates associated with neoplastic involvement of serous 
cavities. AST is elevated in muscular dystrophy, dermatomyositis, bums and pa­
roxysmal myoglobinuria. ALT is elevated in biliary obstruction. AST>ALT in 
alcoholic hepatitis
ALT>AST in viral hepatitis
2. Decreased with pyridoxine (vitamin B6) deficiency (often as a result 
of repeated hemodialysis), renal insufficiency, and pregnancy.
Aminotransferases, Serum: Normal -  AST 8-40 U/L; ALT 5-32 U/L
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Write down the results and make a conclusion:
2. Test for the quantitative determination of potassium with Reflotron.
Diagnostic significance:
A. Physiologic Basis: Potassium concentration in plasma determines 
neuromuscular and muscular irritability. Elevated or decreased concentrations 
impair the capability of muscle tissue to contract.
B. Interpretation:
1. Elevated in renal insufficiency (especially in the presence of in­
creased rate of protein or tissue break down); adrenal insufficiency (especially 
hypoaldosteronism, Addison’s disease); hyporeninemic hypoaldosteronism; de­
hydration; use of spironolactone; too rapid administration of potassium salts, es­
pecially intravenously; and use of triamterene or phenformin.
2. Decreased in-
a. Inadequate intake (starvation).
b. Inadequate absorption or unusual enteric losses -  Vomiting, diarrhea, malab­
sorption syndrome, or use of sodium polystyrene sulfonate resin.
c. Unusual renal loss -  Secondary to hyperadrenocorticism (especially hyperal­
dosteronism, Conn’s syndrome) and to adrenocorticosteroid therapy, metabol­
ic alkalosis, use of diuretics such as chlorothiazide and its derivatives and the 
mercurials; renal tubular defects such as the de Toni-Fanconi syndrome and 
renal tubular acidosis; treatment with antibiotics that are excreted as anions 
(carbenicillin, ticarcillin); use of phenothiazines, amphotericin B, and drugs 
with high sodium content; and use of degraded tetracycline.
d. Abnormal redistribution between extracellular and intracellular fluids -  Fa­
milial periodic paralysis or testosterone administration.
Potassium, Serum or Plasma: Normal: -  Serum: 3.6-5.0 mmol/1; Plas­
ma: 3.8-4.5 mmol/1
Write down the results and make a conclusion:______  _____
3. Test for the quantitative determination of creatine phosphokinase 
with Reflotron.
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Diagnostic significance:
A. Physiologic Basis: creatine phosphokinase (CPK) splits creatine 
phosphate in the presence of ADP to yield creatine and ATP. Skeletal and heart 
muscle and brain are rich in the enzyme. CPK consists of 3 proteins separable 
by electrophoresis. Skeletal muscle is characterized by isoenzyme MM, myo­
cardium by isoenzyme MB, and brain by isoenzyme BB.
B. Interpretation:
1. Elevated in the presence of muscle damage such as with myocardial 
infarction, trauma to muscle, muscular dystrophies, polymyositis, severe muscu­
lar exertion (jogging), hypothyroidism, and cerebral infarction (necrosis). Fol­
lowing myocardial infarction, serum CPK concentration increases rapidly (with­
in 3-5 hours), and it remains elevated for a shorter time after the episode (2 or 3 
days) than does AST or LDH.
CPK-ММ is elevated in injury to skeletal muscle, myocardial muscle, 
and brain; in muscle disease (eg. dystrophies, hypothyroidism, dermatomyositis, 
polymyositis); in rhabdomyolysis; and after severe exercise. CPK-МВ is ele­
vated soon (within 2-4 hours) after myocardial infarction and for up to 72 hours 
afterward (high levels are prolonged with extension of infarct or new infarction); 
also elevated in extensive rhabdomyolysis or muscle injury, severe muscle dis­
ease, Reye's syndrome, or Rocky Mountain spotted fever. CPK-BB is occasio­
nally elevated in severe shock, in some carcinomas (especially oat cell carcino­
ma or carcinoma of the ovary, breast, or prostate), or in biliary atresia.
2. Not elevated in pulmonary infarction or parenchymal liver disease.
Creatine Phosphokinase, Serum: Normal -  female- 25-175 U/L, male
-25-200U/L.
Write down the results and make a conclusion:__________
4. Test for the quantitative cholesterol determination with Reflotron.
Diagnostic significance:
A. Physiologic Basis: Cholesterol concentrations are determined by me­
tabolic functions, which are influenced by heredity, nutrition, endocrine func­
tion, and integrity of vital organs such as the liver and kidney. Cholesterol meta­
bolism is intimately associated with lipid metabolism.
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В. Interpretation:
1. Elevated in familial hypercholesterolemia (xanthomatosis), hypothy­
roidism, poorly controlled diabetes mellitus, nephrotic syndrome, chronic hepa­
titis, biliary cirrhosis, obstructive jaundice, hypoproteinemia (idiopathic, with 
nephrosis or chronic hepatitis), and lipidemia (idiopathic, familial).
2. Decreased in acute hepatitis and Gaucher's disease. Occasionally de­
creased in hyperthyroidism, acute infections, anemia, malnutrition, apolipo- 
protein deficiency, carcinoma, and acute pancreatitis.
Cholesterol, Serum: Normal -  3.65- 5,2 mmol/1 or 140-200 mg/dL.
Write down the results and make a conclusion:_____________________
5. Test for the quantitative determination of pancreatic a-amylase 
with Reflotron.
Diagnostic significance:
A. Physiologic Basis: Normally, small amounts of amylase (diastase), 
molecular weight about 50,000, originating in the pancreas and salivary glands, 
are present in the blood. Inflammatory disease of these glands or obstruction of 
their ducts results in regurgitation of large amounts of enzyme into the blood 
and increased excretion via the kidney.
B. Interpretation:
1. Elevated in acute pancreatitis, pseudocyst of the pancreas, obstruction 
of pancreatic ducts (carcinoma, stone, stricture, duct sphincter spasm after mor­
phine), and mumps. Occasionally elevated in renal insufficiency, in diabetic aci­
dosis, and in inflammation of the pancreas from a perforating peptic ulcer. Rare­
ly, combination o f amylase with an immunoglobulin produces elevated serum 
amylase activity (macroamylasemia) because the large molecular complex (mo­
lecular weight at least 160,000) is not filtered by the glomerulus.
2. Decreased in acute and chronic hepatitis, in pancreatic insufficiency, 
and occasionally, in toxemia of pregnancy.
Amylase, Serum or Urine: Normal -  serum: 16-30 g/Lh; urine: 28-160
g/Lh.
Write down the results and make a conclusion:
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2) Glucose, ketone bodies, proteins determination in urine with me­
thod of "d ry" chemistry by BOEHRINGER MANNHEIM test strips.
A plastic test strip is used, which contains 
pads that have incorporated within them the reagents 
for chemical reactions for the detection of a number 
of urine constituents. Urine is added to the pads for 
reaction by dipping the plastic strip into the urine and 
then slowly withdrawing it. The subsequent colori­
metric reactions are timed to an endpoint; the extent 
of colors formation is directly related to the level of 
the urine constituent. The colors can be read manually by comparison with color 
charts.
Strips test simultaneously are used for the presence of glucose, ketones, 
blood, protein, nitrite, pH, urobilinogen, bilirubin, leucocytes in urine.
Clinical significance:
Proteins. Reagent-strip test for protein is a semi-quantitative screening 
procedure for proteinuria. Most of the urine protein is albumin, which has 
crossed the glomerular membrane. Smaller-molecular-weight proteins such as 
globulins may also be present in urine. Once filtered at the glomerulus, proteins 
are almost completely reabsorbed in the proximal tubule. Proteinuria, therefore, 
can be the result of either increased filtration at the glomerulus or decreased tu­
bular reabsorption. Glomerular proteinuria is associated with the presence of 
larger molecular weight proteins and larger protein losses, usually > 2 g/day. 
The nephrotic syndrome is associated with very large losses of protein, usually 
>2-3 g/day. Tubular proteinuria is associated with smaller amounts (1-3 g/day) 
of lower molecular weight protein molecules. Small losses of protein in urine 
can be seen with vigorous exercise and pregnancy. Normal - a healthy person 
will excrete up to approximately 100 mg/day, a very small fraction of the plasma 
protein that is filtered at the glomerulus.
Sugars: Glucose is the predominant sugar in urine. It is not detectable 
by reagent strips in the urine of healthy individuals. Temporary elevation of glu­
cose excretion measurable by test strips can occur after treatment with some 
drugs, cases of shock and during pregnancy. Repeated positive testing is almost 
always diagnostic for diabetes or pancreatitis. Normal - health individuals nor­
mally will have no detectable sugars in their urine.
Ketones: Ketones are spilled into urine when the body cannot utilize 
glucose (as in diabetes) and metabolize fatty acids. This catabolism is incom­
plete, resulting in the formation of large amounts of acetoacetic acid, acetone 
and beta-hydroxybutyric acid (ketone bodies). The presence of elevated levels of 
ketones in human urine is a primary indicator that the body is in ketosis. Ke­
tones are not stored by the body and are eliminated as detectable waste products 
in urine. Ketone test strips are used routinely to help measure the progress of di-
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eters especially those maintaining a low carbohydrate diet. Additionally, ketones 
are monitored in individuals with Type 1 diabetes. In diabetics, high ketone le­
vels indicate ketoacidosis, a complication of inadequate insulin levels that can 
lead to diabetic coma. In overall health considerations, high ketone levels are 
generally an indication of abnormal nutritional conditions, including starvation, 
fasting, anorexia, vomiting, diarrhea, aspirin overdose, high protein and fat or 
low carbohydrate diets. Normal - health individuals normally will have no de­
tectable ketones in their urine.
Blood: A positive test indicates the presence of red blood cells in the 
urine (hematuria). Hematuria can be renal and extrarenal. The renal is caused 
by pathology of kidneys; extrarenal- by pathology of excretory tract (stones, 
infection, Foley cath). Normal - health individuals normally will have no detect­
able blood in their urine.
Practical procedure:
Place 10-15 ml of urine in the test tube. Dip a strip in urine and wait five 
minutes. If the test color appears somewhat mottled at higher concentrations, 
match the darkest color to the color on the reagent pad. The results can be read 
by visual comparison with a color chart printed on the side of each vial.
Write down the results and make a conclusion:_____________________
Lesson is passed____________________
(The signature o f  the teacher)
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PROGRAM QUESTIONS
Introduction
1. Objects of biochemical studies. Major divisions and trends in biochemistry. 
Place of biochemistry among other biological subjects. Biochemistry and 
medicine.
2. Most important stages in the history of biochemistry. Leading native and 
foreign biochemists, their contribution to the development of biochemistry. 
Biochemistry and development of molecular biology, physical-and-chemical 
biology and biotechnology.
3. Object and aims of biological chemistry. Most important attributes of living 
matter. Manifestations of dialectic laws in organization and functions of liv­
ing matter.
Proteins
4. Proteins as the most important components of the body: their functions, clas­
sification. Shape and size of protein molecules, molecular weight, physical 
and chemical properties.
5. Primary structure of proteins, its role. Hereditary and acquired proteinpa- 
thies. Polymorphism of proteins.
6. Conformation of protein molecule (secondary and tertiary levels). Types of 
intramolecular bonds in protein. Native structure and denaturation of pro­
teins. Protein structure and functional significance. Chaperones, chapero- 
nins.
7. Quaternary structure of proteins. Cooperative changes of protomers confor­
mation (hemoglobin as compared with myoglobin). Ability of proteins to 
specific interactions. Self-organization of polymolecular protein structures.
8. Overall scheme and methods of purification of individual proteins and cha­
racteristics of homogeneity of purified proteins. Quantitative determination 
of proteins.
Enzymes
9. History of discovering and studying enzymes. Specific features of biocata­
lysts. Specificity of enzyme effect on the substrate and type of catalytic reac­
tion. Specific features of enzyme separation. Classification and nomencla­
ture of enzymes.
10. Structural and functional organization of enzymes. Active and allosteric cen­
tres. Isozymes (lactate dehydrogenase, creatine kinase). Mechanism and 
stages of enzyme catalysis. Units of enzyme activity measurement.
11. Effect of substrate and enzyme concentration, temperature and pH on enzy­
matic reaction rate.
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12. Regulation of enzyme action: allosteric mechanisms, cooperative effects, 
chemical modification, action based on feedback regulation, notion of 
proenzymes and multienzyme complexes. Examples of metabolic pathways 
regulated by these mechanisms. Physiological significance of enzyme ac­
tion regulation.
13. Activators and inhibitors of enzymes. Use o f inhibitors as medicines. An­
timetabolites. Enzymodiagnostics, enzymotherapy, hereditary enzymopa­
thies.
Membranes
14. General characteristics and functions of membranes, membrane compo­
nents.
15. Models of membrane structure, transmembrane transport.
Energy
16. Metabolism and its functions, regulation of metabolism in the cell. Intro­
duction to the biochemistry of digestion, properties of food, digestive en­
zymes. Regulation of digestion with hormones of the gastrointestinal tract.
17. Catabolism and anabolism, their integration. Endergonic and exergonic 
reactions in metabolism. ATP and other high energy compounds. 
ADP/ATP cycle. Types of ATP phosphorylation and pathways of APT up­
take.
18. Biological oxidation and pathways of oxygen uptake. Structure of mito­
chondria and structural organization of electron transport chain. Types of 
oxygenated substrates. NAD-linked dehydrogenases. FAD-linked dehydro­
genases: succinate dehydrogenase and acyl-CoA-dehydrogenase.
19. NAD-linked dehydrogenases, composition, mechanism of proton and elec­
tron transport.
20. Internal mitochondrial membrane and respiratory chain: NADH- 
dehydrogenase, ubiquinone, cytochromes, their structure and mechanism of 
proton and electron transfer to oxygen.
21. Oxidative phosphorylation, P/О ratio. Hypotheses of the mechanism of 
oxidative phosphorylation.
22. Coupling of oxidation and phosphorylation in the respiratory chain. Ff - 
ATP-synthase. Respiratory control. Uncouplers of oxidative phosphoryla­
tion. Hypoenergetic conditions.
23. Oxidative systems not associated with energy accumulation. Microsomal 
oxidation. Free radical oxidation. Its role in cell pathology.
24. Common and specific pathways of catabolism. Oxidative decarboxylation 
of pyruvate: composition of pyruvate dehydrogenase complex and se­
quence of reactions.
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25. Citric acid cycle: sequence of reactions and characteristics of enzymes, 
regulation. Biological role of CAC.
Carbohydrates
26. Major carbohydrates of human tissues, their biological role. Digestion of 
carbohydrates, characteristics of enzymes. Scheme of sources and path­
ways of glucose uptake in the body. Key role of glucose-6-phosphate.
27. Glucose metabolism under aerobic condition: sequence of reactions, physi­
ological significance. Shuttle mechanisms of reductive equivalent transfer.
28. Anaerobic glycolysis: sequence of reactions, physiological significance. 
Central oxidation-reduction reaction of glycolysis. Alcoholic fermentation. 
Ethanol metabolism in the body.
29. Glucose biosynthesis (gluconeogenesis), physiological function. Glucose- 
lactate cycle (Cori cycle) and glucose-alanine cycles.
30. Pentose phosphate pathway of glucose metabolism: sequence of reactions, 
biological role.
31. Biosynthesis and glycogen degradation: sequence of reactions, physiologi­
cal significance. Regulation of glycogen phosphorylase and synthase activi­
ty. Glycogenosises and aglycogenosises.
Lipids
32. Major human tissue lipids. Functions of lipids. Deposition and mobilization 
of fats in adipose tissue. Regulation. Transport and uptake of fatty acids. 
Chemical mechanism of glycerol oxidation.
33. Eicosanoids and their role in regulation of metabolism and physiological 
functions.
34. Nutritional fats: digestion, absorption of the products of digestion. Role of 
bile acids. Lipid transport in the body.
35. Transport blood lipoproteins: characteristics, synthesis, physiological role. 
Lipoprotein lipase. Types of hyperlipoproteinamias. Biochemistry o f athe­
rosclerosis.
36. Activation and oxidation of fatty acids: sequence of reactions, physiologi­
cal significance. Biosynthesis and use of ketone bodies.
37. Biosynthesis of fatty acids: synthesis and role of malonyl-CoA, characteris­
tics of palmitate synthase complex, regulation. Production of long-chain 
fatty acids and unsaturated fatty acids.
38. Biosynthesis of triacylglycerols, glycerophospholipids.
39. Metabolism and functions of cholesterol, direct and reverse transport. Bio­
synthesis of cholesterol: sequence of reactions, regulation.
40. Major pathological processes associated with disorders of acetyl-CoA me­
tabolism (fasting, obesity, atherosclerosis, cholelithiasis, diabetes).
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41. Integration of amino acid, fat, carbohydrate metabolism. Manifestations of 
this integration. Major sites of integration (glucose-6-phosphate, pyruvate, 
acetyl-CoA, CAC substrates).
Amino acids
42. Digestion of proteins. Absorption of amino acids. Dynamic state of pro­
teins in the body. Nitrogen balance. Biological value of nutritional proteins 
and protein norms in nutrition. Regulation of digestion by hormones of the 
gastrointestinal tract. Types of acidity of gastric juice.
43. Transamination of amino acids: sequence of reactions, significance. Cha­
racteristics of transaminases. Indirect deamination of amino acids.
44. Oxidative deamination of amino acids: chemical mechanism, characteris­
tics of enzymes. Reductive animation of a-keto-glutarate, its significance.
45. General detoxication of ammonia: synthesis of urea and ammonium salts, 
significance of the processes.
46. Phenylalanine and tyrosine metabolism. Use of tyrosine for synthesis of ca­
techolamines, thyroid hormones, melanins. Tyrosine metabolism into fu- 
marate and acetoacetate. Hereditary defects in phenylalanine and tyrosine 
metabolism.
47. Decarboxylation of amino acids. Production of biogenic amines, their role 
in regulation of metabolism and functions, detoxication.
48. Transmethylation. Methionine and S-adenosylmethionine (participation in 
the synthesis of creatinine, epinephrine, phosphatidylcholine and methyla- 
tion of xenobiotics). Role of tetrahydrofolic acid in methylation.
Nucleic acids. Biosynthesis of proteins
49. Notion of biosynthesis and degradation of purine and pyrimidine nucleo­
tides. Nucleotide metabolism disorders (gout, xanthinuria, protic aciturea).
50. Nucleoproteids. DNA, its structural organization, molecular size, ways of 
packing in chromatin and chromosomes. DNA replication: mechanism and 
biological significance. Replication and phases of the cellular cycle. DNA 
damages and replication errors repair.
51. Primary and secondary structures of RNA. Types of RNA, structure, loca­
lization in the cell, functions. RNA biosynthesis (transcription). Composi­
tion of ribosomes and polyribosomes. Amino acyl-t-RNA synthesis. Sub­
strate nature of amino acyl-t-RNA synthases.
52. Biosynthesis of proteins. Genetic code. Major components of protein- 
synthesizing system. Ribosome functioning and sequence of reactions in 
polypeptide chain synthesis. Adaptive function of t-RNA, role of m-PNA.
53. Regulation of gene activity. Induction and repression of protein synthesis in 
the human body. Role of hormones in the gene activity regulation. Medi-
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cinal preparations as matrix synthesis inhibitors in procaryotes and euca­
ryotes.
Regulation of metabolism. Hormones
54. Sources and pathways of blood glucose uptake. Regulation of blood glucose 
level by insulin, glucagon, epinephrine and glucocorticoids.
55. Hierarchy of regulatory systems. Role of hormones in the system of regula­
tion of metabolism and organ functions. Classification of hormones accord­
ing to their chemical structure and mechanism of action. Major mechanisms 
of metabolic regulation.
56. Central regulation of endocrine system: hormones of hypothalamus and 
tropic hormones of the pituitary.
57. Insulin: structure, synthesis, biological action. Characteristics of metabolic 
disorders in diabetes mellitus. Biochemical mechanisms of development of 
complications in diabetes mellitus.
58. Regulation of water-salt metabolism. Structure, mechanism of action of va­
sopressin and aldosterone. Renin-agiotensin system. Biochemical mechan­
isms of renal hypertension development.
59. Epinephrine and norepinephrine: structure, synthesis, effect on metabolism.
60. Iodothyronines: structure, synthesis, metabolism, their effect on metabol­
ism. Hypo- and hyperthyroidism. Features of thyroid gland functioning in 
connection with Chernobyl accident.
61. Hormones of adrenal cortex: gluco- and mineralocorticosteroids. Their 
structure, effect on metabolism. Manifestation of hyper- and hypofimction.
62. Metabolism of calcium and phosphates: role of parathyroid hormone, calci­
tonin, vitamin D3.
63. Male hormones: structure, effect on metabolism. Anabolics of steroid struc­
ture. Female hormones: structure, role in the sex cycle, effect on metabol­
ism.
64. Major mechanisms of metabolic regulation: changes in enzyme activity, 
amount of enzymes in the cell, membrane permeability. Regulation of car­
bohydrate, fat and amino acid metabolism by glucagon, cortisol and insulin.
Vitamins
65. Vitamins, general characteristics, classification, functions. Pathologic states 
due to vitamin metabolism disorders. Specificity of fat-soluble vitamins.
66. Vitamin A: structure, biological role, sources, recommended dietary allow­
ance. Hypo-, a- and hypervitaminosises.
67. Vitamin D. Structure, biological role, natural sources, recommended dieta­
ry allowance. Hypo-, a- and hypervitaminosises.
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68. Vitamin К: structure, biological role, natural sources, recommended dietary 
allowance, manifestations of deficiency. Water-soluble drugs.
69. Vitamin E: its structure, biological role, natural sources, recommended die­
tary allowance. Manifestations of deficiency.
70. Vitamins C and P, their structure, biological role, natural sources, recom­
mended dietary allowance. Hypo- and avitaminosises.
71. Vitamin By structure, biological role, natural sources, recommended dieta­
ry allowance. Avitaminosis.
72. Vitamin B2 and PP: their structure (co-enzyme forms), biological role, nat­
ural sources, recommended dietary allowance.
73. Biotin. Pantothenic acid. Its structure, biological role (examples of carbox- 
ylation reaction), sources.
74. Folic acid. Structure, folate co-enzymes, recommended dietary allowance. 
Sulfanilamides as antimetabolites.
75. Vitamin B 12. Structure, biological role, natural sources, recommended die­
tary allowance. Pernicious anemia.
Biochemistry of tissues and organs
76. Characteristics of mineral metabolism: calcium, phosphates, zinc, magne­
sium. Functions, metabolism regulation, disorders. Special features o f min­
eral metabolism in connection with Chernobyl accident.
77. Features of water-salt metabolism: distribution of water in the body, water 
balance. Sodium and potassium, their functional role, metabolic disorders. 
Role of kidneys in water-salt metabolism regulation.
78. General characteristics and functions of blood. Erythrocyte proteins. He­
moglobin and its derivatives. Methemoglobinemia. Types of hemoglobin. 
Hemoglobinopathy. Blood plasma proteins and enzymes. Albumins, globu­
lins, their functions. Hyper- and hypoproteinemia.
79. Synthesis of heme and hemoglobin, its regulation. Iron metabolism: trans­
port, deposition, daily requirements. Erythrocytes metabolism: role of gly­
colysis and pentose phosphate pathway.
80. Functional biochemistry of kidneys, specific features of metabolism, func­
tions of kidneys. Urine formation, notion of renal threshold substances.
81. Renal insufficiency, its manifestations. Renal calculi. Urine components, 
proteinuria.
82. Liver, its functions. Specific features of metabolism in the liver. Role of the 
liver in metabolism of carbohydrates, lipids, proteins, amino acids, vita­
mins.
83. Major mechanisms of detoxication of substances in the liver: microsomal 
oxidation, reactions of conjugation. Examples of detoxication of foreign 
substances (phenol), protein putrefaction products (cresol, indole). Signi­
ficance of drug metabolism, factors influencing drug metabolism.
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84. Catabolism of heme. Unconjugated and conjugated bilirubin. Disorders of 
bilirubin metabolism. Types of jaundice. Biochemical'mechanisms of pa­
thogenesis of hepatic insufficiency, serous-biochemical hepatic syndromes.
85. Sarcoplasmic and myofibrillar proteins of muscles. Molecular structure of 
myofibrils. Biochemical mechanisms of muscular contraction and relaxa­
tion. Muscular energetics: role of creatine phosphate, camosine and anse­
rine.
86. General characteristics of connective tissue. Glycosamineglycanes and pro- 
teoglycanes, fibronectin, their structure and biological role. Fibrillar pro­
tein: collagen and elastin, their characteristics and biosynthesis. Role of vi­
tamin C in collagen synthesis. Changes of connective tissue in aging, colla- 
genoses, wound healing.
87. General characteristics and chemical composition of nervous tissue. Specif­
ic features of nervous tissue metabolism. Molecular mechanisms of adre­
nergic and cholinergic transfer, specific features, disorders.
Carcinogenesis
88. Role of physical, chemical and biological factors in carcinogenesis. La­
boratory diagnosis of cancer. Key role of DNA in carcinogenesis. Risk fac­
tors responsible for human carcinogenesis.
89. Role of oncogenes in tumour pathogenesis. Types of oncogenes. Mechan­
isms of protooncogene activation.
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